NCT00211419
|
|
Study of the Combination of Anecortave Acetate and Triamcinolone Acetonide for the Treatment of Exudative Age-Related Macular Degeneration (AMD)
|
Phase 1
|
Completed
|
NCT00002300
|
|
A Study of Different Doses of Megestrol Acetate in Patients With AIDS Who Have Anorexia and Malnutrition
|
Phase 2
|
Completed
|
NCT00000737
|
|
A Phase I/II Study to Evaluate Single Agent and Combination Therapy With Megestrol Acetate and Dronabinol for the Treatment of HIV-Wasting Syndrome
|
Phase 1
|
Completed
|
NCT00501579
|
|
Study of Difluprednate in the Treatment of Uveitis
|
Phase 3
|
Completed
|
NCT00227773
|
|
Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors
|
Phase 2
|
Withdrawn
|
NCT00002345
|
|
The Safety and Effectiveness of Megace in HIV-Infected Women
|
Phase 4
|
Completed
|
NCT00517972
|
|
Omacor for Perimenopausal Depression
|
Phase 2
|
Withdrawn
|
NCT00002167
|
|
Photodynamic Therapy Clinical Trial For Cutaneous AIDS-Related Kaposi's Sarcoma Study Summary.
|
Phase 2
|
Completed
|
NCT00002067
|
|
A Study Comparing Megestrol Acetate at 800 mg/Day, and Placebo in AIDS Patients With Anorexia and Cachexia
|
Phase 3
|
Completed
|
NCT00348244
|
|
Ketorolac vs. Steroid in the Prevention of CME
|
Phase 4
|
Completed
|
NCT00003517
|
|
Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer
|
Phase 2
|
Withdrawn
|
NCT00486772
|
|
Sevelamer, Fetuin-A and Endothelial Dysfunction in CKD
|
Phase 4
|
Completed
|
NCT00211406
|
|
Treatment of Diabetic Retinopathy With Open-Label Anecortave Acetate Sterile Suspension (15 mg)
|
Phase 1
|
Terminated
|
NCT00044837
|
|
Hormone Replacement Therapy and Anti-HIV Drugs in HIV-Infected, Postmenopausal Women
|
Phase 1
|
Terminated
|
NCT00433225
|
|
Efficacy of Topical Ketorolac Versus Placebo for Improving Visual Outcomes Following Multifocal IOL Implantation
|
Phase 4
|
Completed
|
NCT02285244
|
2017-05-01 |
Sotrastaurin Acetate in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia, Prolymphocytic Leukemia, or Richter's Transformation
|
Phase 2
|
Withdrawn
|
NCT02393482
|
2015-04-01 |
Psychological Impact of Amenorrhea in Women With Endometriosis
|
Phase 4
|
Not Yet Recruiting
|
NCT02370537
|
2015-04-01 |
A Study to Investigate How Common Pancreatic Exocrine Insufficiency (PEI) is in Patients With Type 2 Diabetes and Also to Investigate the Uptake of a Single Dose of EPANOVA® or OMACOR® in Patients With Different Degrees of PEI
|
Phase 2
|
Not Yet Recruiting
|
NCT02379390
|
2015-04-01 |
Cabazitaxel Versus the Switch to Alternative AR Targeted Therapy Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Primary Resistant Patients to Abiraterone or Enz
|
Phase 2
|
Not Yet Recruiting
|
NCT02353715
|
2015-04-01 |
Men With Metastatic Castrate-Resistant Prostate Cancer Treated With Either Sipuleucel-T (Provenge®), Abiraterone Acetate (Zytiga®) or Enzalutamide (Xtandi®) Undergoing Cardiopulmonary EXercise Testing
|
Phase 0
|
Not Yet Recruiting
|
NCT01939691
|
2015-03-01 |
Topical Treatment of Uveitic Macular Edema
|
Phase 4
|
Not Yet Recruiting
|
NCT02335203
|
2015-02-01 |
The Effect of Neoadjuvant DMPA on Glandular Cellularity in Women Awaiting Hysterectomy
|
Phase 2
|
Recruiting
|
NCT02361905
|
2015-02-01 |
Ulipristal Acetate for the Preoperative Management of Hypoechoic Cellular Leiomyomas
|
Phase 4
|
Recruiting
|
NCT02357563
|
2015-02-01 |
Ulipristal Acetate Versus GnRH Analogue and Myometrial Preservation
|
Phase 4
|
Recruiting
|
NCT02361892
|
2015-02-01 |
The Effect of Ulipristal Acetate (UPA) on Women Ovarian Reserve
|
Phase 4
|
Recruiting
|
NCT02361879
|
2015-02-01 |
Ulipristal Acetate Versus GnRH Analogue Treatment Before Hysteroscopic Resection of Uterine Leiomyoma
|
Phase 4
|
Recruiting
|
NCT02314156
|
2015-02-01 |
Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy
|
Phase 2
|
Not Yet Recruiting
|
NCT02228681
|
2015-02-01 |
Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer
|
Phase 2
|
Not Yet Recruiting
|
NCT02278185
|
2015-02-01 |
Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer
|
Phase 2
|
Not Yet Recruiting
|
NCT02160353
|
2015-01-01 |
Janssen Neo-adjuvant Abiraterone Prostate Study
|
Phase 2
|
Not Yet Recruiting
|
NCT02346253
|
2015-01-01 |
High-Dose Brachytherapy in Treating Patients With Prostate Cancer
|
Phase 1/Phase 2
|
Recruiting
|
NCT02323646
|
2014-12-01 |
A Phase 2, Study to Evaluate the Safety and Efficacy Proellex® (Telapristone Acetate) Administered Vaginally in the Treatment of Uterine Fibroids
|
Phase 2
|
Recruiting
|
NCT02301897
|
2014-12-01 |
A Multi-Center, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 6 and 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine Fibroids
|
Phase 2
|
Recruiting
|
NCT02336620
|
2014-12-01 |
Balanced Salt Solution VS. Normal Saline Solution in Septic Shock
|
Phase 3
|
Active, Not Recruiting
|
NCT02272647
|
2014-12-01 |
Progesterone Amplifies Estrogen-stimulated Growth Hormone Secretion in Older Women
|
Phase 1
|
Not Yet Recruiting
|
NCT01973816
|
2014-11-01 |
MEdical Versus SUrgical Treatments of Rectal Endometriosis
|
Phase 3
|
Recruiting
|
NCT02269670
|
2014-11-01 |
Everolimus and Hormone Therapy in Treating Patients With Advanced Hormone Receptor Positive Breast Cancer That Has Progressed or Recurred on Everolimus and Exemestane Therapy
|
Phase 2
|
Recruiting
|
NCT02257736
|
2014-11-01 |
An Efficacy and Safety Study of JNJ56021927 in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)
|
Phase 3
|
Recruiting
|
NCT02268175
|
2014-10-01 |
Enzalutamide/Leuprolide +/- Abiraterone/Pred in Prostate
|
Phase 2
|
Recruiting
|
NCT02230046
|
2014-10-01 |
Bioequivalence Study of Abiraterone Acetate Coated and Uncoated Tablet Formulations in Healthy Male Participants
|
Phase 1
|
Completed
|
NCT02203331
|
2014-10-01 |
Bay98-7196, Dose Finding / POC Study
|
Phase 2
|
Recruiting
|
NCT02309385
|
2014-10-01 |
Safety and Efficacy Study of DSP-Visulex for the Treatment of Anterior Uveitis
|
Phase 1/Phase 2
|
Recruiting
|
NCT02212197
|
2014-09-01 |
Phase II Study of Subcutaneous Injection Depot of Leuprolide Acetate in Patient With Prostate Cancer
|
Phase 2
|
Recruiting
|
NCT02159690
|
2014-09-01 |
A Phase II Neoadjuvant Study of Enzalutamide, Abiraterone Acetate, Dutasteride and Degarelix in Men With Localized Prostate Cancer Pre-prostatectomy
|
Phase 2
|
Withdrawn
|
NCT02364531
|
2014-09-01 |
A Canadian Observational Study in Metastatic Cancer of the Prostate: A Study of ZYTIGA Use in the Community Urology Setting
|
Phase 4
|
Recruiting
|
NCT02217566
|
2014-09-01 |
Study of Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC), Chemo-Naive, Who Received a Prior Diethylstilbestrol Therapy
|
Phase 2
|
Recruiting
|
NCT02125357
|
2014-08-01 |
Sequencing Abiraterone and Enzalutamide in mCRPC
|
Phase 2
|
Recruiting
|
NCT02218606
|
2014-08-01 |
Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in Treatment of Metastatic Castration Resistant Prostate Cancer
|
Phase 2
|
Recruiting
|
NCT02195635
|
2014-07-01 |
Phase 1, Open-label, Drug-drug Interaction Study With Octreotide Acetate Injection and Telotristat Etiprate in Healthy Subjects
|
Phase 1
|
Active, Not Recruiting
|
NCT02123758
|
2014-07-01 |
A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer
|
Phase 1
|
Recruiting
|
NCT02090114
|
2014-06-01 |
RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistant (The RESTORE Study)
|
Phase 2
|
Recruiting
|
NCT01763541
|
2014-06-01 |
Study of the Effect of Testosterone and Estradiol on NP Responses to Acute and Chronic Salt Loading
|
Phase 0
|
Withdrawn
|
NCT02077634
|
2014-05-01 |
Trial of Abiraterone Acetate Plus LHRH-therapy Versus Abiraterone Acetate Sparing LHRH-therapy in Patients With Progressive Chemotherapy-naïve Castration-resistant Prostate Cancer (SPARE)
|
Phase 2
|
Recruiting
|
NCT02058706
|
2014-05-01 |
LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Metastatic Hormone Sensitive Prostate Cancer
|
Phase 2
|
Recruiting
|
NCT02075606
|
2014-05-01 |
Circulating Tumour Cells in Somatuline Autogel Treated NeuroEndocrine Tumours Patients
|
Phase 4
|
Recruiting
|
NCT02064582
|
2014-05-01 |
Enzalutamide and Hormone Therapy Before, During, and After Radiation for High Risk Localized Prostate Cancer
|
Phase 2
|
Recruiting
|
NCT02141061
|
2014-05-01 |
Comparison of Two Formulations of Proellex for Oral Administration
|
Phase 1
|
Completed
|
NCT01994590
|
2014-05-01 |
Dovitinib (TKI258) and Abiraterone Acetate in Metastatic Castrate-Resistant Prostate Cancer (mCRPC)
|
Phase 2
|
Active, Not Recruiting
|
NCT01961934
|
2014-05-01 |
C11-Sodium Acetate PET/CT Imaging Evaluation in Brain Glioma, Post Therapy Necrosis and Pseudo-progression
|
Phase 2/Phase 3
|
Recruiting
|
NCT02023463
|
2014-04-01 |
Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer
|
Phase 1
|
Recruiting
|
NCT02103660
|
2014-04-01 |
Clinical Trial on the Effects of Progestin-based Contraception in the Genital Tract of HIV-infected and Uninfected Women
|
Phase 4
|
Active, Not Recruiting
|
NCT02147197
|
2014-04-01 |
A Study of the Efficacy and Safety of a Single Ulipristal Treatment Course for the Treatment of Abnormal Uterine Bleeding Associated With Leiomyomas
|
Phase 3
|
Recruiting
|
NCT02097303
|
2014-03-01 |
Open Label Phase Two Trial of Radium Ra 223 Dichloride With Concurrent Administration of Abiraterone Acetate Plus Prednisone in Symptomatic Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Bone Metastasis
|
Phase 2
|
Recruiting
|
NCT01953679
|
2014-03-01 |
Efficacy Study of Two Continuous Regimens of Oral Daily 5 mg or 10 mg of Ulipristal Acetate (UPA), Versus a Dose of 5.0mg UPA for 24/4 Days
|
Phase 2
|
Recruiting
|
NCT02115282
|
2014-03-01 |
Exemestane With or Without Entinostat in Treating Postmenopausal Patients With Recurrent Hormone Receptor-Positive Breast Cancer That Is Locally Advanced or Metastatic
|
Phase 3
|
Recruiting
|
NCT02178449
|
2014-03-01 |
Prolongation of Pain Free Time by the Use of Dexamethasone in Peripheral Nerve Blockade
|
Phase 4
|
Recruiting
|
NCT01943058
|
2014-03-01 |
Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial Cancer
|
Phase 2
|
Withdrawn
|
NCT01976728
|
2014-02-01 |
LutrePulse Hypogonadotropic Hypogonadism
|
Phase 3
|
Recruiting
|
NCT02147158
|
2014-01-01 |
A Study of the Safety and Efficacy of Intermittent Ulipristal Treatment of Abnormal Uterine Bleeding Associated With Leiomyomas
|
Phase 3
|
Recruiting
|
NCT02003209
|
2014-01-01 |
Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer
|
Phase 3
|
Recruiting
|
NCT02023424
|
2014-01-01 |
An Open Label, Exploratory Study to Investigate the Treatment Effect of Glatiramer Acetate on Girls Woth Rett Syndrome
|
Phase 1
|
Recruiting
|
NCT02034552
|
2013-12-01 |
A Randomized Phase IIa Efficacy and Safety Study of Radium-223 Dichloride With Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (CRPC)
|
Phase 2
|
Recruiting
|
NCT02025010
|
2013-12-01 |
Phase II Clinical Trial of Abiraterone Acetate Without Exogenous Glucocorticoids in Men With Castration-resistant Prostate Cancer With Correlative Assessment of Hormone Intermediates.
|
Phase 2
|
Recruiting
|
NCT02140632
|
2013-12-01 |
Efficacy Study of Local Steroid Injection and Wrist Splinting for Carpal Tunnel Syndrome
|
Phase 4
|
Enrolling By Invitation
|
NCT01843530
|
2013-11-01 |
Randomized, Double-blind, Two Arms, Multicenter, Phase III Study of Berinert for Treatment of ACE Induced Angioedema
|
Phase 3
|
Recruiting
|
NCT01989780
|
2013-11-01 |
Bevacizumab Plus Paclitaxel Optimization Study With Interventional Maintenance Endocrine Therapy in Advanced or Metastatic ER-positive Human Epidermal Growth Factor Receptor 2(HER2)-Negative Breast Cancer
|
Phase 2
|
Recruiting
|
NCT01913158
|
2013-10-01 |
Safety and Efficacy Study of Anucort HC TM 25mg Rectal Suppositories to Treat Symptomatic Internal Hemorrhoids
|
Phase 2
|
Active, Not Recruiting
|
NCT01940276
|
2013-10-01 |
Abiraterone Race in Metastatic Castrate-resistant Prostate Cancer
|
Phase 2
|
Recruiting
|
NCT01946165
|
2013-10-01 |
Abiraterone Acetate Plus LHRH Agonist and Abiraterone Acetate Plus LHRH Agonist and Enzalutamide
|
Phase 2
|
Active, Not Recruiting
|
NCT01963611
|
2013-10-01 |
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
|
Phase 2
|
Active, Not Recruiting
|
NCT01968317
|
2013-10-01 |
Megestrol Acetate Plus Metformin to Megestrol Acetate in Patients With Endometrial Atypical Hyperplasia or Early Stage Endometrial Adenocarcinoma
|
Phase 2
|
Recruiting
|
NCT01957436
|
2013-10-01 |
A Phase III of ADT +/- Local RT +/- Abiraterone Acetate in Metastatic Hormone-naïve Prostate Cancer.
|
Phase 3
|
Recruiting
|
NCT01916252
|
2013-09-01 |
Bortezomib (Velcade®), Lenalidomide (Revlimid®) and IV Busulfan (Busilvex®) in Patients Under 65 Years Old
|
Phase 3
|
Recruiting
|
NCT01950403
|
2013-09-01 |
Linaclotide Acetate in Preventing Colorectal Cancer in Healthy Volunteers
|
Phase 1
|
Active, Not Recruiting
|
NCT01003769
|
2013-09-01 |
Lenalidomide and AT-101 in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
|
Phase 1/Phase 2
|
Recruiting
|
NCT01501396
|
2013-09-01 |
Megestrol Acetate With or Without Mirtazapine in Treating Cancer Patients With Weight Loss or Loss of Appetite
|
Phase 2
|
Withdrawn
|
NCT01953965
|
2013-09-01 |
Look at Way the Heart Functions in People With Pulmonary Hypertension (PH) Who Have Near Normal Right Ventricle (RV) Function and People With Pulmonary Hypertension Who Have Impaired RV Function. Using Imaging Studies PET Scan and Cardiac MRI.
|
Phase 2
|
Recruiting
|
NCT01717053
|
2013-09-01 |
Abiraterone, Radiotherapy and Short-Term Androgen Deprivation in Unfavorable Localized Prostate Cancer
|
Phase 2
|
Recruiting
|
NCT01917136
|
2013-08-01 |
11C-acetate/18Fluorodeoxyglucose-FDG PET/CT and Cardiac MRI in Pulmonary Hypertension
|
Phase 2
|
Recruiting
|
NCT02153723
|
2013-08-01 |
Pharmacological Treatment of Rett Syndrome With Glatiramer Acetate (Copaxone)
|
Phase 2
|
Recruiting
|
NCT01848067
|
2013-08-01 |
Alisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer
|
Phase 1/Phase 2
|
Recruiting
|
NCT02103764
|
2013-08-01 |
Efficacy of Cyclic DSG Compared With Cyclic MPA for the Treatment of Anovulatory DUB
|
Phase 3
|
Recruiting
|
NCT01913015
|
2013-07-01 |
Dietary Fat Levels and Abiraterone Acetate Uptake in Patients With Metastatic Hormone-Resistant Prostate Cancer
|
Phase 1
|
Terminated
|
NCT01842321
|
2013-07-01 |
Abiraterone Acetate in Molecular Apocrine Breast Cancer
|
Phase 2
|
Recruiting
|
NCT01475643
|
2013-07-01 |
Loteprednol vs Prednisolone for the Treatment of Intraocular Inflammation Following Cataract Surgery in Children.
|
Phase 3
|
Recruiting
|
NCT02340013
|
2013-07-01 |
Endometrial Shedding Prior to Ovulation Induction Pilot Study
|
Phase 4
|
Recruiting
|
NCT01723579
|
2013-07-01 |
Efficacy and Safety of Oral NOMAC-E2 in Indian Women (P07057/MK-8175A-017)
|
Phase 3
|
Withdrawn
|
NCT01878708
|
2013-07-01 |
A Pilot Study of Oncaspar® + Dexamethasone in Patients With Relapsed or Refractory T-Cell Lymphoma
|
Phase 0
|
Recruiting
|
NCT01867710
|
2013-07-01 |
Abiraterone With Different Steroid Regimens for Side Effect Related to Mineralcorticoid Excess Prevention in Prostate Cancer Prior to Chemotherapy
|
Phase 2
|
Recruiting
|
NCT01845792
|
2013-07-01 |
Study of Abiraterone Acetate and Prednisone in Combination With Cabazitaxel in Patients With Prostate Cancer
|
Phase 2
|
Recruiting
|
NCT01853072
|
2013-06-01 |
Nepafenac Once Daily for Macular Edema - Study 1
|
Phase 3
|
Active, Not Recruiting
|
NCT01834209
|
2013-06-01 |
A Study of Abiraterone Acetate Plus Prednisone in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer
|
Phase 3
|
Completed
|
NCT01872611
|
2013-06-01 |
Nepafenac Once Daily for Macular Edema - Study 2
|
Phase 3
|
Active, Not Recruiting
|
NCT01800422
|
2013-06-01 |
Oral CDB-4124 vs. Placebo in Stage I-II Primary Breast Cancer
|
Phase 2
|
Recruiting
|
NCT01692483
|
2013-06-01 |
Post-marketing Surveillance Study on the Safety and Effectiveness of Abiraterone Acetate Among Adult Filipino Male Patients With Advanced Metastatic Castration Resistant Prostate Cancer
|
Phase 4
|
Withdrawn
|
NCT01814865
|
2013-05-01 |
Anti-Proliferative Effects and Genomic Alterations of Abiraterone Acetate Compared to an Aromatase Inhibitor in Post-menopausal HR+ Operable Breast Cancer
|
Phase 2
|
Withdrawn
|
NCT01873001
|
2013-05-01 |
A Study to Assess the Effect of Abiraterone (JNJ-589485) on the Pharmacokinetics of Pioglitazone Following Administration of Abiraterone Acetate (JNJ-212082) and Pioglitazone HCl Tablets in Healthy Male Participants
|
Phase 1
|
Completed
|
NCT01640964
|
2013-04-01 |
An Exploratory Haemodynamic Study in Patients With Compensated Cirrhosis and Portal Hypertension
|
Phase 2
|
Recruiting
|
NCT01674140
|
2013-04-01 |
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
|
Phase 3
|
Recruiting
|
NCT01853696
|
2013-03-01 |
Comparison of Corticosteroid Dosing Regimens After Endothelial Keratoplasty
|
Phase 4
|
Active, Not Recruiting
|
NCT01503515
|
2013-03-01 |
Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant
|
Phase 3
|
Recruiting
|
NCT01637402
|
2013-03-01 |
A Phase II Study of Increased-Dose Abiraterone Acetate in Patients With Castration Resistant Prostate Cancer
|
Phase 2
|
Active, Not Recruiting
|
NCT01771328
|
2013-02-01 |
Continuous Subcutaneous Hydrocortisone Infusion in Congenital Adrenal Hyperplasia
|
Phase 2
|
Recruiting
|
NCT01715285
|
2013-02-01 |
A Study of Abiraterone Acetate Plus Low-Dose Prednisone Plus Androgen Deprivation Therapy (ADT) Versus ADT Alone in Newly Diagnosed Participants With High-Risk, Metastatic Hormone-Naive Prostate Cancer (mHNPC)
|
Phase 3
|
Active, Not Recruiting
|
NCT01786265
|
2013-02-01 |
Finite Androgen Ablation vs. Finite Androgen Ablation in Combination With Abiraterone Acetate and Prednisone
|
Phase 2
|
Recruiting
|
NCT01792687
|
2013-02-01 |
Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumor Activity of Ascending Doses of ARN 509 in Combination With Abiraterone Acetate
|
Phase 1
|
Active, Not Recruiting
|
NCT01868269
|
2013-02-01 |
Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)
|
Phase 3
|
Recruiting
|
NCT01776008
|
2013-01-01 |
Akt Inhibitor MK-2206 and Anastrozole With or Without Goserelin Acetate in Treating Patients With Stage II-III Breast Cancer
|
Phase 2
|
Recruiting
|
NCT01670656
|
2013-01-01 |
A Study to Evaluate the Effect of Vaginal Rings on Primary Dysmenorrhea (P08257/MK-8175A/MK-8342B-057)
|
Phase 2
|
Completed
|
NCT01817530
|
2013-01-01 |
Safety and Efficacy in Premenopausal Women With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)
|
Phase 2
|
Active, Not Recruiting
|
NCT01717898
|
2013-01-01 |
A Multicenter Phase I/II Trial of Abiraterone Acetate + BEZ235 in Metastatic, Castration-Resistant Prostate Cancer
|
Phase 1/Phase 2
|
Terminated
|
NCT01777061
|
2013-01-01 |
Clinical Management Decisions for Recurrent Prostate Cancer Patients Based on [11C]Acetate PET Scan
|
Phase 3
|
Available
|
NCT01709318
|
2012-12-01 |
A Dose-Finding Study to Evaluate Ovarian Function and Vaginal Bleeding in Next Generation Rings (P06109/MK-8175A/MK-8342B-012)
|
Phase 2
|
Completed
|
NCT01767090
|
2012-12-01 |
A Study to Assess the Effectiveness and Safety of Different Doses of ASP1707 Compared to Placebo for Endometriosis Associated Pelvic Pain
|
Phase 2
|
Active, Not Recruiting
|
NCT01735396
|
2012-12-01 |
Abiraterone Acetate Trial in African American Prostate Cancer Patients
|
Phase 2
|
Recruiting
|
NCT01751451
|
2012-12-01 |
3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy
|
Phase 2
|
Recruiting
|
NCT01681433
|
2012-12-01 |
OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone
|
Phase 2
|
Recruiting
|
NCT01503229
|
2012-12-01 |
Abiraterone Acetate in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
|
Phase 2
|
Recruiting
|
NCT01822288
|
2012-12-01 |
The Impact of Hormone Therapy on Lower Urinary Tract Symptoms, Sexual Function and Psychosomatic Disorder
|
Phase 4
|
Recruiting
|
NCT01747668
|
2012-11-01 |
Lactation Fortification Study
|
Phase 3
|
Completed
|
NCT01708044
|
2012-11-01 |
Effect of Different Fixed Pramlintide:Insulin Dose Ratios on Postprandial Glucose in T1DM
|
Phase 1
|
Completed
|
NCT01778283
|
2012-10-01 |
Comparison of Cardiac Index and Cardiac Output Effect During Maintenance Hemodialysis Between Acetate-Free and Acetate-Based Online Hemodiafiltration
|
Phase 4
|
Completed
|
NCT01712867
|
2012-10-01 |
The Effect of Phytosterol Esters of Omega-3 (Vayarol) Versus Omega-3 Acids Ethyl Esters in Reducing Triglyceride Levels
|
Phase 4
|
Active, Not Recruiting
|
NCT01696877
|
2012-09-01 |
A Neoadjuvant Study of Androgen Ablation Combined With Cyclophosphamide and GVAX Vaccine for Localized Prostate Cancer
|
Phase 1/Phase 2
|
Active, Not Recruiting
|
NCT01638026
|
2012-09-01 |
Final Oocyte Maturation Via Administration of GnRH Agonists Followed By Luteal Support With hCG
|
Phase 4
|
Active, Not Recruiting
|
NCT01631903
|
2012-09-01 |
Extension of Study ZPV-200
|
Phase 2
|
Completed
|
NCT01685125
|
2012-09-01 |
Abiraterone Acetate and Prednisone With or Without Dasatinib in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
|
Phase 2
|
Recruiting
|
NCT01695135
|
2012-08-01 |
A Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Docetaxel-Based Chemotherapy
|
Phase 3
|
Active, Not Recruiting
|
NCT01678573
|
2012-07-01 |
A Study to Evaluate the Pharmacokinetics of Abiraterone in Healthy Chinese Male Participants
|
Phase 1
|
Completed
|
NCT01469338
|
2012-07-01 |
Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel
|
Phase 2
|
Terminated
|
NCT01642472
|
2012-07-01 |
PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata
|
Phase 3
|
Active, Not Recruiting
|
NCT01608698
|
2012-06-01 |
Comparison of Body Weight Change During Contraception With Belara and Yasmin
|
Phase 4
|
Enrolling By Invitation
|
NCT01595373
|
2012-06-01 |
Local Metabolic Effects of Ghrelin in Skeletal Muscle and Adipose Tissue
|
Phase 0
|
Completed
|
NCT01650194
|
2012-06-01 |
A Study to Determine Safety and Tolerability of Enzalutamide (MDV3100) in Combination With Abiraterone Acetate in Bone Metastatic Castration-Resistant Prostate Cancer Patients
|
Phase 2
|
Active, Not Recruiting
|
NCT01640093
|
2012-05-01 |
A Comparative Study of Bioavailability of 3 New Abiraterone Acetate Tablets With Current Commercial Tablet
|
Phase 1
|
Completed
|
NCT01546987
|
2012-05-01 |
Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer
|
Phase 3
|
Active, Not Recruiting
|
NCT01530269
|
2012-04-01 |
C11-Sodium Acetate PET/CT Imaging for Metastatic Disease in Intermediate-to-high Risk Prostate Adenocarcinoma
|
Phase 2
|
Recruiting
|
NCT01553123
|
2012-04-01 |
Efficacy and Safety Study of Ulipristal Acetate in Females With Anemia Associated With Uterine Leiomyoma
|
Phase 3
|
Withdrawn
|
NCT00888082
|
2012-04-01 |
Protection of Ovarian Function With Goserelin Acetate in Premenopausal Early Breast Cancer Patients With Chemotherapy
|
Phase 3
|
Withdrawn
|
NCT01576770
|
2012-04-01 |
In Children, Does Using a Synera Patch Decrease Pain When Injecting Propofol at Anesthesia Induction?
|
Phase 4
|
Recruiting
|
NCT01517802
|
2012-03-01 |
A Study That Provides Long-term Safety Follow-up and Examines Long-term Exposure to Abiraterone Acetate
|
Phase 3
|
Active, Not Recruiting
|
NCT01569113
|
2012-03-01 |
Assessment of Effects on Ovarian Activity of a Combined Oral Contraceptive Pill When Preceded by the Intake of ellaOne® or Placebo.
|
Phase 4
|
Completed
|
NCT02107391
|
2012-03-01 |
Phase II Study of DCVAC/PCa Added to Hormone Therapy for Men With Metastatic Prostate Cancer
|
Phase 2
|
Active, Not Recruiting
|
NCT01791413
|
2012-03-01 |
Effect of Pre-operative Depo Medroxyprogesterone Acetate on Serum Anti-mullerian Hormone Level After Laparoscopic Ovarian Cystectomy of Endometriomas
|
Phase 1/Phase 2
|
Completed
|
NCT01288378
|
2012-03-01 |
Empirical Versus Preemptive Antifungal Therapy
|
Phase 3
|
Recruiting
|
NCT01404117
|
2012-03-01 |
A Multinational, Randomized, Double-blind, Parallel-group, Placebo-controlled Study Assessing the Safety and Tolerability
|
Phase 2
|
Withdrawn
|
NCT01421368
|
2012-03-01 |
Contraception and Menstrual Cycle Effect on Pharmacokinetics, Pharmacodynamics and Safety in Tenofovir Vaginal Gel Use
|
Phase 1
|
Active, Not Recruiting
|
NCT01591122
|
2012-03-01 |
Study of Abiraterone Acetate Plus Prednisone in Patients With Chemo-naive Metastatic Castration-Resistant Prostate Cancer
|
Phase 3
|
Active, Not Recruiting
|
NCT01452685
|
2012-03-01 |
A Long-term Extension Study of TAK-385 in the Treatment of Endometriosis
|
Phase 2
|
Completed
|
NCT01511536
|
2012-03-01 |
Cabazitaxel and Abiraterone Acetate in Patients With Metastatic Castrate-Resistant Prostate Cancer
|
Phase 1
|
Completed
|
NCT01652495
|
2012-03-01 |
Evaluation of Efficacy and Hypothalamus-pituitary-adrenal Axis Suppression Due to Corticosteroids Intrabursal Injection
|
Phase 4
|
Completed
|
NCT01576172
|
2012-03-01 |
Abiraterone Acetate and Prednisone With or Without Veliparib in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
|
Phase 2
|
Recruiting
|
NCT01578785
|
2012-03-01 |
An Efficacy, Safety and Tolerability Study of Glatiramer Acetate (GA) 20 mg/0.5 ml New Formulation Administered Daily by Subcutaneous (SC) Injection in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS)
|
Phase 3
|
Terminated
|
NCT01569451
|
2012-02-01 |
Comparison of Rituximab Induction Therapy Followed by Glatiramer Acetate Therapy to Glatiramer Acetate Monotherapy for MS
|
Phase 2
|
Active, Not Recruiting
|
NCT01776203
|
2012-01-01 |
Study of a Progestin to Prevent Bleeding Associated With Initiation of Medical Menopause With GnRH Agonist
|
Phase 4
|
Terminated
|
NCT01655147
|
2012-01-01 |
A Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of Abiraterone in Healthy Male Participants
|
Phase 1
|
Completed
|
NCT01669499
|
2012-01-01 |
Dexamethasone for Pain Flare After Radiotherapy of Painful Bone metastasesZonMW 11510009
|
Phase 3
|
Recruiting
|
NCT01534182
|
2012-01-01 |
Evaluation of Patient Reported Outcomes in RRMS Patients Candidates for MS Therapy Change and Transitioned to Fingolimod 0.5 mg (EPOC)
|
Phase 4
|
Completed
|
NCT01543776
|
2012-01-01 |
Food Effect Study of Abiraterone Acetate for Treatment of Patients With Castration-Resistant Prostate Cancer
|
Phase 2
|
Recruiting
|
NCT01487863
|
2011-12-01 |
Concurrent Versus Sequential Treatment With Sipuleucel-T and Abiraterone in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)
|
Phase 2
|
Active, Not Recruiting
|
NCT01495910
|
2011-12-01 |
A Study Examining Doses of Abiraterone Acetate in Adult Women With 21-Hydroxylase Deficiency
|
Phase 1
|
Completed
|
NCT01505088
|
2011-12-01 |
Safety and Efficacy Study of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution to Treat Non-Infectious Anterior Segment Uveitis
|
Phase 3
|
Completed
|
NCT01482897
|
2011-12-01 |
Efficacy of corticoïd Infiltration Via Sacro-coccygien Hiatus in Discal Sciatica
|
Phase 3
|
Terminated
|
NCT01712295
|
2011-11-01 |
17% Salicylate Versus 17% Salicylate-Ethyl Pyruvate for Plantar Foot Warts
|
Phase 4
|
Recruiting
|
NCT01463202
|
2011-11-01 |
Timing of Postpartum Depot Medroxyprogesterone Acetate Administration on Breastfeeding, Contraceptive Continuation, and Depression
|
Phase 4
|
Recruiting
|
NCT01511120
|
2011-11-01 |
The Effect on Fluid Balance After Cardiac Surgery After Use of Two Different Priming Protocols
|
Phase 2
|
Recruiting
|
NCT01489254
|
2011-10-01 |
Efficacy and Safety of GTR in Comparison to Copaxone®
|
Phase 3
|
Completed
|
NCT01448213
|
2011-10-01 |
Comparison of Two Steroid Regimens to Prevent Transplant Rejection After Corneal Transplant (DMEK)
|
Phase 2
|
Completed
|
NCT01396213
|
2011-10-01 |
A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease
|
Phase 2
|
Completed
|
NCT01458301
|
2011-10-01 |
Efficacy and Safety of TAK-385 in the Treatment of Endometriosis
|
Phase 2
|
Completed
|
NCT01368263
|
2011-09-01 |
Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer
|
Phase 2
|
Terminated
|
NCT01461824
|
2011-09-01 |
Drug Exposure and Depot Medroxyprogesterone Acetate (DMPA) in Adolescent Subjects
|
Phase 3
|
Active, Not Recruiting
|
NCT01431391
|
2011-09-01 |
Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer
|
Phase 2
|
Completed
|
NCT01427907
|
2011-09-01 |
Equivalence of Calcium Acetate Oral Solution and Sevelamer Carbonate Tablets in Hemodialysis Patients
|
Phase 4
|
Active, Not Recruiting
|
NCT01415960
|
2011-09-01 |
Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate Cancer
|
Phase 3
|
Active, Not Recruiting
|
NCT01309672
|
2011-09-01 |
S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy
|
Phase 2
|
Active, Not Recruiting
|
NCT01441635
|
2011-09-01 |
Safety and Efficacy Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids
|
Phase 2
|
Completed
|
NCT01393730
|
2011-09-01 |
Abiraterone Acetate Combined With Dutasteride for Metastatic Castrate Resistant Prostate Cancer
|
Phase 2
|
Active, Not Recruiting
|
NCT01581359
|
2011-09-01 |
The Effect of Pre-treatment With GnRH Analogues Prior in Vitro Fertilization in Patients With Endometriosis
|
Phase 4
|
Recruiting
|
NCT01413620
|
2011-08-01 |
Vitamin E Supplementation in Burn Patients
|
Phase 1
|
Recruiting
|
NCT01381874
|
2011-08-01 |
A Study of Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastrozole Therapy
|
Phase 2
|
Active, Not Recruiting
|
NCT01431690
|
2011-08-01 |
Interaction of Epanova on Warfarin Pharmacokinetic and Anticoagulant Activity and Comparison of the Effects of Epanova and Lovaza on Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) After Low-fat Meals
|
Phase 1
|
Completed
|
NCT01421173
|
2011-08-01 |
Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid Malignancies
|
Phase 1
|
Active, Not Recruiting
|
NCT01685983
|
2011-08-01 |
A Study of Abiraterone Acetate (JNJ-212082) and Prednisolone in Patients With Advanced Prostate Cancer
|
Phase 2
|
Active, Not Recruiting
|
NCT01634321
|
2011-07-01 |
The Clinical Trial to Evaluate the Efficacy and Safety of Luphere Depot Inj. 3.75mg(Leuprolide Acetate 3.75mg) in Patients With Precocious Puberty
|
Phase 4
|
Completed
|
NCT01442246
|
2011-06-01 |
Benefit Evaluation of Adjuvant Hormonal Treatment for 24 Months After Radical Prostatectomy in High Risk of Recurrence Patients.
|
Phase 3
|
Active, Not Recruiting
|
NCT01362764
|
2011-05-01 |
A Study to Assess the Relative Bioavailability of Two Abiraterone Acetate Suspension Formulations Compared to the Abiraterone Acetate Tablet Formulation in Healthy Adult Volunteers
|
Phase 1
|
Completed
|
NCT01296152
|
2011-05-01 |
Pharmacokinetic Interactions Between DMPA and LPV/Rit Among HIV-Infected Women
|
Phase 2
|
Completed
|
NCT01314118
|
2011-05-01 |
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
|
Phase 2
|
Active, Not Recruiting
|
NCT01257802
|
2011-05-01 |
GnRH-a for Ovarian Protection During CYC Therapy for Rheumatic Diseases
|
Phase 3
|
Recruiting
|
NCT01317004
|
2011-05-01 |
Patients With RRMS:Candidates for MS Therapy Change
|
Phase 4
|
Completed
|
NCT01510106
|
2011-04-01 |
Ferric Citrate in Patients With End-Stage Renal Disease on Dialysis
|
Phase 3
|
Completed
|
NCT01304485
|
2011-04-01 |
PET Imaging Characteristics of C11-Acetate in Patients With Recurrent Prostate Carcinoma
|
Phase 2
|
Recruiting
|
NCT01629173
|
2011-04-01 |
The Analysis and Applications of Dynamic Impression Insole
|
Phase 0
|
Completed
|
NCT01307579
|
2011-04-01 |
Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy
|
Phase 3
|
Recruiting
|
NCT01254864
|
2011-03-01 |
Maximum Androgen Depletion
|
Phase 2
|
Active, Not Recruiting
|
NCT01200602
|
2011-03-01 |
Megestrol Acetate in Treating Weight Loss or Anorexia in Young Patients With Malignancies Who Are Undergoing Radiation Therapy and/or Chemotherapy
|
Phase 2
|
Terminated
|
NCT00939549
|
2011-03-01 |
High Dose Cyclophosphamide Followed by Glatiramer Acetate in the Treatment of Relapsing Remitting Multiple Sclerosis
|
Phase 2
|
Suspended
|
NCT01291433
|
2011-03-01 |
Trial of Combined Pentoxifylline-tocopherol-clodronate vs Placebo in Radiation-induced Brachial Plexopathy
|
Phase 3
|
Recruiting
|
NCT01009931
|
2011-03-01 |
Phase II Study of TPA Plus Dexamethasone & CMT in Hematologic Malignancies
|
Phase 2
|
Active, Not Recruiting
|
NCT01391052
|
2011-01-01 |
Pretreatment With Norethindrone Acetate Prior to Levonorgestrel IUS Insertion for Heavy Menstrual Bleeding
|
Phase 4
|
Recruiting
|
NCT01277497
|
2011-01-01 |
Effect of Phosphate Binders on Markers of Vascular Health in Chronic Kidney Disease Stages 3 and 4
|
Phase 4
|
Recruiting
|
NCT01191177
|
2011-01-01 |
Investigational Study of Oral Fish Oil in Treating Parenteral Nutrition Associated Liver Disease
|
Phase 1/Phase 2
|
Recruiting
|
NCT01120236
|
2010-12-01 |
Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer
|
Phase 2
|
Active, Not Recruiting
|
NCT00961532
|
2010-12-01 |
Improving Platelet Activity for Cerebral Hemorrhage Treatment - DDAVP Proof of Concept
|
Phase 2
|
Completed
|
NCT01250886
|
2010-12-01 |
Acid-base Balance in Patients Undergoing Colonoscopy
|
Phase 1
|
Enrolling By Invitation
|
NCT01045798
|
2010-12-01 |
Pilot Feasibility Study With Patients Who Are at High Risk For Developing Invasive Candidiasis in a Critical Care Setting (MK-0991-067)
|
Phase 2
|
Terminated
|
NCT01162460
|
2010-12-01 |
Efficacy and Safety of Eslicarbazepine Acetate as Monotherapy for Patients With Newly Diagnosed Partial-onset Seizures
|
Phase 3
|
Active, Not Recruiting
|
NCT01129960
|
2010-11-01 |
Eslicarbazepine Acetate as Therapy in Diabetic Neuropathic Pain
|
Phase 3
|
Terminated
|
NCT01216982
|
2010-11-01 |
Effects of Omega-3 EPA/DHA for Soldiers at Risk for Mood Disorders
|
Phase 2
|
Active, Not Recruiting
|
NCT01247961
|
2010-11-01 |
Early Treatment With Dexamethasone in Mild Acute Pancreatitis
|
Phase 2
|
Recruiting
|
NCT01217697
|
2010-11-01 |
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
|
Phase 3
|
Active, Not Recruiting
|
NCT01229943
|
2010-10-01 |
Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed by Surgery
|
Phase 2
|
Active, Not Recruiting
|
NCT01191255
|
2010-10-01 |
A 58-Week Safety and Efficacy Trial of Ferric Citrate in Patients With ESRD on Dialysis
|
Phase 3
|
Completed
|
NCT01201798
|
2010-10-01 |
Safety and Efficacy of Difluprednate 0.05% for the Treatment of Anterior Uveitis
|
Phase 3
|
Completed
|
NCT01149356
|
2010-10-01 |
RO4929097 And Exemestane in Treating Pre- and Postmenopausal Patients With Advanced or Metastatic Breast Cancer
|
Phase 1/Phase 2
|
Terminated
|
NCT01204476
|
2010-10-01 |
Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma
|
Phase 1
|
Active, Not Recruiting
|
NCT01194271
|
2010-09-01 |
Neoadjuvant Ipilimumab in Prostate Cancer
|
Phase 2
|
Active, Not Recruiting
|
NCT01199146
|
2010-09-01 |
Abiraterone Post Ketoconazole for Prostate Cancer
|
Phase 2
|
Active, Not Recruiting
|
NCT01124097
|
2010-09-01 |
Eslicarbazepine Acetate as Therapy in Post-Herpetic Neuralgia
|
Phase 3
|
Terminated
|
NCT01124045
|
2010-08-01 |
Difluprednate Pediatric Study for the Treatment of Inflammation Post-Cataract Surgery
|
Phase 3
|
Completed
|
NCT01527513
|
2010-08-01 |
Effects of Eslicarbazepine Acetate (Esl, Bia 2-093) on Cognitive Function in Children With Partial Onset Seizures
|
Phase 2
|
Completed
|
NCT01180764
|
2010-08-01 |
Effects of Lovaza on High Density Lipoprotein (HDL) Composition and Function in Hypertriglyceridemia
|
Phase 4
|
Withdrawn
|
NCT01160848
|
2010-08-01 |
Photoactive Porphyrins (PAP) Levels After Topical Visonac Application in Acne Patients
|
Phase 2
|
Completed
|
NCT01278290
|
2010-07-01 |
Comparative Validation of the Triptorelin Test for the Diagnosis of CPP in Girls
|
Phase 4
|
Active, Not Recruiting
|
NCT01161563
|
2010-07-01 |
Randomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue Administration
|
Phase 4
|
Completed
|
NCT01163084
|
2010-07-01 |
Leuprolide Acetate or Goserelin Acetate With or Without Vismodegib Followed by Surgery in Treating Patients With Locally Advanced Prostate Cancer
|
Phase 1/Phase 2
|
Active, Not Recruiting
|
NCT01167426
|
2010-07-01 |
Evaluation of Two Glatiramer Acetate (GA) Formulations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients
|
Phase 3
|
Completed
|
NCT01144897
|
2010-06-01 |
PET Acetate for Castrate-Resistant Prostate Cancer on Chemotherapy
|
Phase 2
|
Active, Not Recruiting
|
NCT01091662
|
2010-06-01 |
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
|
Phase 3
|
Completed
|
NCT01156311
|
2010-05-01 |
BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis
|
Phase 2
|
Completed
|
NCT01067521
|
2010-05-01 |
A Study in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS) to Assess the Efficacy, Safety and Tolerability of Glatiramer Acetate (GA) Injection 40 mg Administered Three Times a Week Compared to Placebo
|
Phase 3
|
Active, Not Recruiting
|
NCT01140217
|
2010-05-01 |
Efficacy and Safety Study of Norethindrone Acetate Transdermal Delivery System in Contraception
|
Phase 3
|
Completed
|
NCT01422720
|
2010-04-01 |
Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients
|
Phase 4
|
Completed
|
NCT01359475
|
2010-04-01 |
A Clinical Trial of an Acetal Resin Crown for Restoration of Primary Molars
|
Phase 3
|
Completed
|
NCT01023061
|
2010-03-01 |
Abiraterone Acetate, Prednisone, and Leuprolide Acetate or Goserelin Before and During Radiation Therapy in Treating Patients With Localized or Locally Advanced Prostate Cancer
|
Phase 2
|
Active, Not Recruiting
|
NCT01058005
|
2010-03-01 |
Study Evaluating Rebif, Copaxone, and Tysabri for Active Multiple Sclerosis
|
Phase 3
|
Terminated
|
NCT01086982
|
2010-03-01 |
Pharmacodynamics Of Product Octreotide Acetate Lar 30 Mg, Imported And Distributed By The Laboratory Chemical Pharmaceutical Bergamo Ltda., Compared To Product Sandostatin LAR ® (Octreotide Acetate LAR) 30 MG Manufactured By Novartis Biosciences S / A.
|
Phase 1
|
Suspended
|
NCT01071083
|
2010-03-01 |
Treatment Interruption of Natalizumab
|
Phase 2
|
Completed
|
NCT01011621
|
2010-02-01 |
Efficacy and Tolerability of Prednisolone Acetate 0.5% Cream Versus Betamethasone Valerate 0.1% Cream in Cortisosensitive Dermatosis
|
Phase 3
|
Not Yet Recruiting
|
NCT01065220
|
2010-02-01 |
Sex Steroids and the Serotonin Transporter
|
Phase 4
|
Completed
|
NCT01017939
|
2010-01-01 |
A Drug-Drug Interaction Study of Abiraterone Acetate Plus Prednisone With Dextromethorphan and Theophylline in Patients With Metastatic Castration-Resistant Prostate Cancer
|
Phase 1
|
Completed
|
NCT01047683
|
2009-12-01 |
Efficacy and Safety of AMR101 (Ethyl Icosapentate) in Patients With Fasting Triglyceride (Tg) Levels ≥ 500 and ≤ 2000 mg/dL
|
Phase 3
|
Completed
|
NCT00962156
|
2009-12-01 |
Scandinavian Starch for Severe Sepsis/Septic Shock Trial
|
Phase 3
|
Completed
|
NCT01088529
|
2009-12-01 |
Neo-adjuvant Abiraterone + Luteinizing Hormone-Releasing Hormone (LHRH) Versus LHRH in Prostate Cancer
|
Phase 2
|
Completed
|
NCT00997893
|
2009-12-01 |
Research Investigation of Soy and Estrogen
|
Phase 2
|
Recruiting
|
NCT01047501
|
2009-12-01 |
Effect of AMR101 (Ethyl Icosapentate) on Triglyceride (Tg) Levels in Patients on Statins With High Tg Levels (≥ 200 and < 500 mg/dL)
|
Phase 3
|
Completed
|
NCT01103518
|
2009-12-01 |
Ethinyl Estradiol and Cyproterone Acetate in Irregular Menstruation
|
Phase 4
|
Active, Not Recruiting
|
NCT00935168
|
2009-12-01 |
Crystalloid Versus Hydroxyethyl Starch Trials
|
Phase 3
|
Completed
|
NCT01350973
|
2009-11-01 |
Efficacy of TAK-085 in Participants With Hypertriglyceridemia
|
Phase 3
|
Completed
|
NCT00843570
|
2009-11-01 |
Natural Versus HRT Cycles in Frozen Embryo Replacement Treatment
|
Phase 4
|
Completed
|
NCT01350999
|
2009-11-01 |
Long-term Efficacy and Safety Study of TAK-085 in Participants With Hypertriglyceridemia
|
Phase 3
|
Completed
|
NCT00931879
|
2009-10-01 |
Lovaza® and Microvascular Function in Type 2 Diabetes
|
Phase 4
|
Completed
|
NCT01076803
|
2009-10-01 |
Efficacy and Safety of Lanreotide 120 Milligram (mg) as a Palliative Treatment of Clinical Symptoms Associated With Malignant Intestinal Obstruction in Inoperable Patients
|
Phase 2
|
Completed
|
NCT00937768
|
2009-10-01 |
Leuprolide Acetate or Goserelin Acetate Compared With Observation in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy
|
Phase 2
|
Terminated
|
NCT00949962
|
2009-10-01 |
Post-operative or Early Salvage XRT and ADT for High Risk PCa
|
Phase 3
|
Terminated
|
NCT01798628
|
2009-09-01 |
A Study to Determine the Effect of Food on the Pharmacokinetics of Abiraterone Acetate in Healthy Male Patients
|
Phase 1
|
Completed
|
NCT00936390
|
2009-09-01 |
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
|
Phase 3
|
Recruiting
|
NCT00910598
|
2009-09-01 |
Optical Coherence Tomography: Glatiramer in Clinically Isolated Syndrome or Early Relapsing Remitting Multiple Sclerosis (MS)
|
Phase 4
|
Recruiting
|
NCT01715259
|
2009-08-01 |
A Pharmacokinetic Study of Abiraterone Acetate in Male Participants With Impaired Renal Function Compared to Individuals With Normal Renal Function
|
Phase 1
|
Completed
|
NCT00910091
|
2009-08-01 |
The Study of Oral Steroid Sulphatase Inhibitor BN83495 Versus Megestrol Acetate (MA) in Women With Advanced or Recurrent Endometrial Cancer
|
Phase 2
|
Completed
|
NCT00910247
|
2009-08-01 |
Eslicarbazepine Acetate Monotherapy Long Term Study
|
Phase 3
|
Active, Not Recruiting
|
NCT02001571
|
2009-08-01 |
A Study to Assess the Effect of Abiraterone Acetate in Male Participants With Mild or Moderate Hepatic Impairment Compared to Matched Control Participants With Normal Hepatic Function
|
Phase 1
|
Completed
|
NCT00891072
|
2009-07-01 |
Gossypol, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
|
Phase 1
|
Completed
|
NCT01550146
|
2009-07-01 |
Single Dose of Dexamethasone in Femur Fractures
|
Phase 4
|
Recruiting
|
NCT00947752
|
2009-07-01 |
Safety of New Formulation of Glatiramer Acetate
|
Phase 3
|
Completed
|
NCT00934219
|
2009-07-01 |
Triglyceride Lowering Study
|
Phase 4
|
Recruiting
|
NCT00915902
|
2009-07-01 |
Fish Oil Study for High Triglyceride Levels in Children
|
Phase 2/Phase 3
|
Completed
|
NCT00987558
|
2009-06-01 |
Effect of Repeated Administration of Eslicarbazepine Acetate on the Pharmacokinetics of Simvastatin in Healthy Subjects
|
Phase 1
|
Completed
|
NCT01624727
|
2009-06-01 |
Slowing HEART diSease With Lifestyle and Omega-3 Fatty Acids
|
Phase 3
|
Active, Not Recruiting
|
NCT00927901
|
2009-06-01 |
Efficacy, Safety, Tolerability, and Pharmacokinetics of Indacaterol Salts in Patients With Asthma
|
Phase 2
|
Completed
|
NCT00946920
|
2009-06-01 |
A Trial of Degarelix in Patients With Prostate Cancer
|
Phase 3
|
Completed
|
NCT00844012
|
2009-05-01 |
Continuous Postoperative Use of Low-Dose Combined Oral Contraceptivesfor for Endometriosis-Related Chronic Pelvic Pain
|
Phase 4
|
Not Yet Recruiting
|
NCT00910754
|
2009-05-01 |
A QT/QTc and Multi-Dose Pharmacokinetic Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer
|
Phase 1
|
Completed
|
NCT00866775
|
2009-04-01 |
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
|
Phase 3
|
Completed
|
NCT01991574
|
2009-04-01 |
Effect of the Consumption of Ferric Hydroxide Adipate on Urinary Phosphorus Excretion.
|
Phase 0
|
Completed
|
NCT00887198
|
2009-04-01 |
Abiraterone Acetate in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer
|
Phase 3
|
Active, Not Recruiting
|
NCT00889473
|
2009-04-01 |
Study of the Efficacy of AT1001 (Larazotide Acetate) to Treat Celiac Disease
|
Phase 2
|
Completed
|
NCT00865540
|
2009-03-01 |
Effect of Anti-inflammatory Topical Prednisolone, Nepafenac and Ketorolac in Intra-operative Mydriasis in Facetectomies
|
Phase 4
|
Active, Not Recruiting
|
NCT00860158
|
2009-03-01 |
Neoadjuvant Dasatinib Plus LHRH Analogue Therapy in High-Risk Localized Prostate Cancer
|
Phase 2
|
Terminated
|
NCT01244334
|
2009-03-01 |
Study of Difluprednate vs. Prednisolone Acetate on Visual Acuity, and Corneal Edema Following Cataract Surgery.
|
Phase 4
|
Completed
|
NCT00805870
|
2009-03-01 |
The Effects of High Dose Fish Oil Supplementation on Delayed Onset Muscle Soreness and Inflammatory Markers
|
Phase 2
|
Completed
|
NCT00848016
|
2009-02-01 |
Gossypol Acetic Acid in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By Surgery
|
Phase 2
|
Completed
|
NCT00856635
|
2009-02-01 |
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of the Effects of Glatiramer Acetate (GA) on the Retinal Nerve Fiber Layer (RNFL) and Visual Function in Patients With a First Episode of Acute Optic Neuritis (AON). (Octagon)
|
Phase 3
|
Completed
|
NCT00828178
|
2009-02-01 |
Efficacy of Fish Oil in Lupus Patients
|
Phase 4
|
Completed
|
NCT01148420
|
2009-01-01 |
DMPA & High Dose Oral Progestin (MPA) Tablets in Outpatient Treatment of Acute Excessive Vaginal Bleeding
|
Phase 4
|
Completed
|
NCT00805935
|
2009-01-01 |
Menopur® Versus Follistim® in Polycystic Ovarian Syndrome (PCOS)
|
Phase 4
|
Completed
|
NCT01218737
|
2009-01-01 |
Non-Inferiority of Gatifloxacin/Prednisolone Association vs Isolated Administration in Prevention of Ocular Infection/Inflammation
|
Phase 3
|
Completed
|
NCT00808132
|
2009-01-01 |
Study Evaluating The Effects Of Bazedoxifene/Conjugated Estrogens On Endometrial Safety And Postmenopausal Osteoporosis
|
Phase 3
|
Completed
|
NCT00833495
|
2009-01-01 |
Evaluation of Efficacy of Coadministration of FOV1101-00 and Prednisolone Acetate in Patients With Mild Ongoing Ocular Allergic Inflammation
|
Phase 2
|
Completed
|
NCT00943956
|
2009-01-01 |
Everolimus, Bicalutamide, and Leuprolide Acetate in Treating Patients Undergoing Radiation Therapy For High-Risk Locally Advanced Prostate Cancer
|
Phase 1
|
Recruiting
|
NCT01113671
|
2009-01-01 |
Type 2 Diabetes Haptoglobin Phenotype and Vitamin E
|
Phase 2/Phase 3
|
Completed
|
NCT00788541
|
2008-12-01 |
A Dose-Volume Study of a Treatment for Elevated IOP Due to Open-Angle Glaucoma or Ocular Hypertension
|
Phase 2
|
Terminated
|
NCT00988429
|
2008-12-01 |
Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures
|
Phase 3
|
Active, Not Recruiting
|
NCT00667446
|
2008-12-01 |
Safety Extension Study Of Leuprolide Acetate (Lupron Depot) In The Treatment Of Central Precocious Puberty
|
Phase 3
|
Completed
|
NCT01123538
|
2008-12-01 |
Progestagen Type in Postmenopausal Hormone Therapy and Blood Gene Expression Profile
|
Phase 4
|
Active, Not Recruiting
|
NCT00773955
|
2008-11-01 |
R-(-)-Gossypol Acetic Acid in Treating Patients With Recurrent Extensive-Stage Small Cell Lung Cancer
|
Phase 2
|
Completed
|
NCT00791089
|
2008-11-01 |
Effects of Fish Oil on Post Ablation Arrhythmias
|
Phase 4
|
Recruiting
|
NCT00782717
|
2008-11-01 |
A Clinical Safety and Efficacy Comparison of NEVANAC 0.1% to Vehicle After Cataract Surgery in Diabetic Retinopathy Patients
|
Phase 2
|
Completed
|
NCT01185704
|
2008-11-01 |
Analysis of Two Therapeutic With Cetrotide® in Polycystic Ovarian (PCO) Women in Assisted Reproductive Technology (ART)
|
Phase 3
|
Completed
|
NCT00900237
|
2008-11-01 |
Study to Evaluate Pharmacokinetics and Tolerability of Multiple Doses of Eslicarbazepine Acetate and Oxcarbazepine
|
Phase 1
|
Completed
|
NCT00755885
|
2008-10-01 |
Abiraterone Acetate in Treating Postmenopausal Women With Advanced or Metastatic Breast Cancer
|
Phase 1/Phase 2
|
Recruiting
|
NCT00924807
|
2008-09-01 |
Safety Study of Sorafenib With Androgen Deprivation and Radiotherapy to Treat Prostate Cancer
|
Phase 1/Phase 2
|
Terminated
|
NCT00427349
|
2008-09-01 |
AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors
|
Phase 2
|
Active, Not Recruiting
|
NCT00898560
|
2008-09-01 |
Effect of Repeat Administration of Eslicarbazepine Acetate on the Pharmacokinetics of a Combined Oral Contraceptive
|
Phase 1
|
Completed
|
NCT00731172
|
2008-09-01 |
A Double Blind Placebo Control Study to Assess the Safety,Tolerability and Efficacy of Copaxone in Crohn's Disease
|
Phase 2
|
Recruiting
|
NCT00729586
|
2008-09-01 |
Temsirolimus With or Without Megestrol Acetate and Tamoxifen Citrate in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer
|
Phase 2
|
Active, Not Recruiting
|
NCT00924313
|
2008-09-01 |
Positron Emission Tomography and Magnetic Resonance Imaging for Prostate Cancer
|
Phase 1/Phase 2
|
Completed
|
NCT00742820
|
2008-08-01 |
Bioequivalence Study Comparing Calcium Acetate Oral Solution Versus Calcium Acetate Gelcaps in Healthy Volunteers
|
Phase 1
|
Completed
|
NCT00717860
|
2008-08-01 |
A Clinical Study of MK0991 (Caspofungin) in Japanese Patients With Deep-seated Candida or Aspergillus Infections (0991-062)(COMPLETED)
|
Phase 3
|
Completed
|
NCT00739830
|
2008-08-01 |
Clinical Trial of Ridaforolimus Compared to Progestin or Chemotherapy for Advanced Endometrial Carcinoma (MK-8669-007 AM6)
|
Phase 2
|
Completed
|
NCT00758199
|
2008-07-01 |
Determination of Optimum Duration of Treatment With Bromfenac (Xibrom) Eyedrops Following Cataract Surgery
|
Phase 4
|
Completed
|
NCT00771017
|
2008-07-01 |
Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer
|
Phase 2
|
Withdrawn
|
NCT01654653
|
2008-07-01 |
Efficacy and Safety of Hypertonic Sodium Lactate Solution Compared With 6% HES Solution in CABG Patients
|
Phase 4
|
Completed
|
NCT00755924
|
2008-06-01 |
Prospective Randomized Clinical Trial Evaluating the Impact of Vinegar on High Density Lipoprotein
|
Phase 1
|
Completed
|
NCT00635817
|
2008-06-01 |
A Study of Leuprolide 11.25 mg and 30 mg Administered Every 3 Months to Treat Central Precocious Puberty
|
Phase 3
|
Completed
|
NCT00823004
|
2008-06-01 |
Antagonist/Letrozole in Poor Responders
|
Phase 1/Phase 2
|
Completed
|
NCT00691717
|
2008-06-01 |
Anecortave Acetate Safety in Patients With Open-Angle Glaucoma or Ocular Hypertension
|
Phase 2/Phase 3
|
Completed
|
NCT00706784
|
2008-06-01 |
Ethylvinyl Acetate (EVA) Vaginal Ring Delivery System Study
|
Phase 1/Phase 2
|
Terminated
|
NCT00696410
|
2008-06-01 |
The Impact of Zinc Supplementation on Left Ventricular Function in Nonischemic Cardiomyopathy
|
Phase 1
|
Completed
|
NCT00694746
|
2008-06-01 |
Study of Fish Oil to Reduce ALT Levels in Adolescents
|
Phase 1
|
Recruiting
|
NCT00705770
|
2008-05-01 |
A Multi-Dose Study With a Treatment for Open-Angle Glaucoma
|
Phase 2/Phase 3
|
Withdrawn
|
NCT01107093
|
2008-05-01 |
Comparison of CDB-2914 Versus Placebo in the Prevention of Follicular Rupture Post-luteinizing Hormone (LH) Surge
|
Phase 2
|
Completed
|
NCT00687739
|
2008-05-01 |
Prevention of Obesity in Women Via Estradiol Regulation
|
Phase 3
|
Recruiting
|
NCT00689078
|
2008-05-01 |
Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge Model
|
Phase 4
|
Completed
|
NCT00638690
|
2008-05-01 |
Abiraterone Acetate in Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
|
Phase 3
|
Completed
|
NCT00630799
|
2008-05-01 |
Efficacy and Safety Study of a New Leuprolide Acetate 17 mg Depot to Treat Prostate Cancer Patients
|
Phase 3
|
Terminated
|
NCT00673387
|
2008-04-01 |
Study to Examine Safety, Tolerability, and Effect on Body Weight of Metreleptin Administered in Conjunction With Pramlintide in Obese and Overweight Subjects
|
Phase 2
|
Completed
|
NCT00528866
|
2008-04-01 |
Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy
|
Phase 2
|
Active, Not Recruiting
|
NCT00651261
|
2008-04-01 |
Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
|
Phase 3
|
Active, Not Recruiting
|
NCT00211432
|
2008-04-01 |
Treatment of Pseudovitellium Detachment With Open-Label Anecortave Acetate Sterile Suspension (15 mg)
|
Phase 2
|
Completed
|
NCT00651326
|
2008-03-01 |
Androgen Suppression Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With High-Risk Localized Prostate Cancer
|
Phase 3
|
Terminated
|
NCT00620451
|
2008-02-01 |
Randomized, Double-Blind, Placebo-Controlled Study of Larazotide Acetate (AT-1001) in Active Celiac Disease
|
Phase 2
|
Completed
|
NCT00626431
|
2008-02-01 |
A Study of Leuprolide to Treat Prostate Cancer
|
Phase 3
|
Completed
|
NCT01135615
|
2008-01-01 |
Sevelamer, FGF-23 and Endothelial Dysfunction in Chronic Kidney Disease (CKD)
|
Phase 4
|
Completed
|
NCT00540722
|
2008-01-01 |
Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
|
Phase 2
|
Completed
|
NCT00635648
|
2008-01-01 |
A Study of Caspofungin Acetate (MK0991) for the Treatment of Esophageal Candidiasis or Invasive Candidiasis in Chinese Adults (MK-0991-066)
|
Phase 3
|
Completed
|
NCT00601276
|
2007-12-01 |
Comparison of Two Pharmacological Treatments of Pedophilia
|
Phase 3
|
Terminated
|
NCT00988156
|
2007-12-01 |
Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children
|
Phase 3
|
Active, Not Recruiting
|
NCT00569127
|
2007-12-01 |
Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
|
Phase 3
|
Active, Not Recruiting
|
NCT00589472
|
2007-11-01 |
Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer
|
Phase 2
|
Active, Not Recruiting
|
NCT00981227
|
2007-11-01 |
Efficacy and Safety of Eslicarbazepine Acetate as Therapy for Patients With Post-Herpetic Neuralgia
|
Phase 2
|
Completed
|
NCT00980746
|
2007-11-01 |
Efficacy and Safety of Eslicarbazepine Acetate as Therapy for Patients With Painful Diabetic Neuropathy
|
Phase 2
|
Completed
|
NCT00605267
|
2007-10-01 |
Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment
|
Phase 3
|
Completed
|
NCT00286234
|
2007-10-01 |
Niacin, N-3 Fatty Acids and Insulin Resistance
|
Phase 4
|
Completed
|
NCT00541047
|
2007-10-01 |
Radiation Therapy and Androgen Deprivation Therapy in Treating Patients Who Have Undergone Surgery for Prostate Cancer (RADICALS)
|
Phase 3
|
Recruiting
|
NCT00811395
|
2007-10-01 |
Long Term Safety of Teriflunomide When Added to Interferon-Beta or Glatiramer Acetate in Patients With Multiple Sclerosis
|
Phase 2
|
Completed
|
NCT00971295
|
2007-10-01 |
Effect of Eslicarbazepine Acetate on the Pharmacokinetics of Metformin in Healthy Volunteers
|
Phase 1
|
Completed
|
NCT00532558
|
2007-10-01 |
Efficacy of Lapaquistat Acetate on Blood Cholesterol Levels in Treating Subjects With Hypercholesterolemia
|
Phase 3
|
Terminated
|
NCT01596010
|
2007-10-01 |
Investigation of 2 Different Oral Formulations of Estradiol and Norethisterone in Healthy Women
|
Phase 1
|
Completed
|
NCT00544440
|
2007-10-01 |
An Observational Study of Continuous Oral Dosing of Abiraterone Acetate in Castration-Resistant Prostate Cancer Patients Evaluating Androgens and Steroid Metabolites in Bone Marrow Plasma
|
Phase 2
|
Completed
|
NCT00512668
|
2007-09-01 |
Hormone Therapy and Temsirolimus in Treating Patients With Relapsed Prostate Cancer
|
Phase 1
|
Terminated
|
NCT00544596
|
2007-09-01 |
R-(-)-Gossypol Acetic Acid, Cisplatin, and Etoposide in Treating Patients With Advanced Solid Tumors or Extensive Stage Small Cell Lung Cancer
|
Phase 1
|
Completed
|
NCT00474851
|
2007-08-01 |
The Effect of Hormonal Add-Back Therapy in Adolescents Treated With a GnRH Agonist for Endometriosis: A Randomized Trial
|
Phase 2
|
Completed
|
NCT00865228
|
2007-07-01 |
Efficacy of Lapaquistat Acetate in Subjects With Hypercholesterolemia
|
Phase 2
|
Terminated
|
NCT00600535
|
2007-07-01 |
A Pharmacokinetics Study to Assess Abiraterone Acetate Capsule and Tablet Formulations in Patients With Prostate Cancer
|
Phase 1
|
Completed
|
NCT01144143
|
2007-07-01 |
Treatment Of Knee Osteoarthritis With Intra-Articular Infliximab
|
Phase 4
|
Completed
|
NCT00577122
|
2007-07-01 |
Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast Cancer
|
Phase 2
|
Completed
|
NCT00503581
|
2007-07-01 |
Megestrol in Treating Patients With Endometrial Neoplasia or Endometrial Hyperplasia
|
Phase 2
|
Active, Not Recruiting
|
NCT00532311
|
2007-07-01 |
Efficacy of Lapaquistat Acetate Co-Administered With Statins in Subjects With Hypercholesterolemia
|
Phase 3
|
Terminated
|
NCT01056042
|
2007-06-01 |
Efficacy of Injectable Contraceptive and Oral Contraceptive Administered After Surgical Treatment of Endometriosis With Pain
|
Phase 4
|
Completed
|
NCT00451451
|
2007-06-01 |
Efficacy and Safety Study of Oral BG00012 With Active Reference in Relapsing-Remitting Multiple Sclerosis
|
Phase 3
|
Completed
|
NCT00485303
|
2007-06-01 |
An Efficacy and Safety Study of Abiraterone Acetate and Prednisone in Participants With Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy
|
Phase 2
|
Completed
|
NCT00503516
|
2007-06-01 |
Study to Evaluate the Effect of Megestrol Acetate in Weight Loss in Dementia Patients
|
Phase 2/Phase 3
|
Terminated
|
NCT00483327
|
2007-06-01 |
Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate
|
Phase 2
|
Completed
|
NCT00688961
|
2007-06-01 |
Effects of Omacor and Aspirin on Platelet Function
|
Phase 0
|
Completed
|
NCT00489840
|
2007-05-01 |
Treatment of Chronic Central Serous Chorioretinopathy With Open-Label Anecortave Acetate
|
Phase 1/Phase 2
|
Completed
|
NCT00452556
|
2007-05-01 |
The ELDORADO (Eligard®, Docetaxel and Radiotherapy) Study
|
Phase 2
|
Active, Not Recruiting
|
NCT00467649
|
2007-05-01 |
A Study to Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 Diabetes
|
Phase 4
|
Completed
|
NCT00477490
|
2007-05-01 |
Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia
|
Phase 3
|
Completed
|
NCT00711607
|
2007-05-01 |
A Trial to Assess the Pharmacokinetic Profile (e.g., Uptake, Distribution and Excretion of a Substance in the Body) of Nomegestrol Acetate (NOMAC), Estradiol (E2) and Estrone (E1) After Multiple and Single Dose Administration of the Combined Oral Contraception NOMAC-E2 (COMPLETED)(P05822)
|
Phase 1
|
Completed
|
NCT00616551
|
2007-04-01 |
Efficacy and Safety of C2L-OCT-01 PR in Acromegalic Patients
|
Phase 3
|
Completed
|
NCT00447499
|
2007-04-01 |
Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
|
Phase 3
|
Completed
|
NCT00598312
|
2007-04-01 |
Safety and Efficacy Study of Leuprolide Acetate for Injectable Suspension 22.5 MG in the Treatment of Prostate Cancer
|
Phase 3
|
Completed
|
NCT00475865
|
2007-04-01 |
Phase II Study of Teriflunomide as Adjunctive Therapy to Glatiramer Acetate in Subjects With Multiple Sclerosis
|
Phase 2
|
Completed
|
NCT00460811
|
2007-04-01 |
Randomized, Double-blind, Dose-range-finding, Phase 2 Study of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
|
Phase 2
|
Completed
|
NCT00439751
|
2007-04-01 |
Immediate Versus Deferred Androgen Deprivation Therapy,Goserelin for Recurrent Prostate Cancer After Radical Radiotherapy
|
Phase 3
|
Active, Not Recruiting
|
NCT01664728
|
2007-04-01 |
An Expanded Access Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer Who Have Completed Clinical Study COU-AA-001
|
Phase 1
|
Completed
|
NCT00451152
|
2007-03-01 |
Safety and Efficacy of Anecortave Acetate in Patients With Open-Angle Glaucoma
|
Phase 2
|
Completed
|
NCT00718289
|
2007-03-01 |
Citrate- Versus Acetate-Based Dialysate in Bicarbonate Haemodialysis: Consequences on Haemodynamics, Coagulation, Acid-Base Status and Electrolytes
|
Phase 4
|
Completed
|
NCT00442767
|
2007-02-01 |
Post-meal Insulin Dosing With Adjuvant Pre-meal Pramlintide in Children With Type 1 Diabetes Mellitus
|
Phase 4
|
Completed
|
NCT00435045
|
2007-02-01 |
Evaluation of Efficacy and Safety of Omacor, Co-Administered With Atorvastatin, in Subjects With Hypertriglyceridemia
|
Phase 3
|
Completed
|
NCT00498901
|
2007-02-01 |
Letrozole and Goserelin or Leuprolide in Treating Premenopausal Estrogen Receptor-Positive Patients With Stage IV Breast Cancer
|
Phase 2
|
Terminated
|
NCT00913055
|
2007-02-01 |
Open Label Study of Octreotide Implant in Patients With Acromegaly
|
Phase 2
|
Completed
|
NCT01157182
|
2007-02-01 |
Estradiol/Norethindrone Acetate Tablets, 1/0.5 mg Under Fasting Conditions
|
Phase 1
|
Completed
|
NCT00390403
|
2007-02-01 |
Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
|
Phase 1
|
Completed
|
NCT00633347
|
2007-01-01 |
Use of Antagonist Versus Agonist GnRH in Oocyte Recipient Endometrium Preparation
|
Phase 4
|
Completed
|
NCT00420342
|
2007-01-01 |
Effects of Angeliq and Prempro on Blood Pressure and Sodium Sensitivity in Postmenopausal Women With Prehypertension
|
Phase 2
|
Completed
|
NCT00380406
|
2007-01-01 |
PROtecting Ovaries and Fertility During Chemotherapy - The PROOF Trial
|
Phase 3
|
Completed
|
NCT00051129
|
2007-01-01 |
Anecortave Acetate in Subfoveal Choroidal Neovascularization (CNV) Due to Wet Age-Related Macular Degeneration (AMD)
|
Phase 3
|
Completed
|
NCT00453960
|
2007-01-01 |
Genistein and Endometrial Hyperplasia
|
Phase 2
|
Completed
|
NCT01181726
|
2007-01-01 |
Estradiol/Norethindrone Acetate Tablets, 1/0.5 mg Under Fed Conditions
|
Phase 1
|
Completed
|
NCT00402337
|
2006-11-01 |
Dose-range-finding, Phase 2 Trial of Oral Linaclotide Acetate Administered to Patients With Chronic Constipation
|
Phase 2
|
Completed
|
NCT00487591
|
2006-11-01 |
An Evaluation of Simvastatin Plus Omacor Compared to Simvastatin Plus Placebo in Subjects With Mixed Dyslipidemia
|
Phase 4
|
Completed
|
NCT00474383
|
2006-11-01 |
An Safety and Efficacy Study of Abiraterone Acetate in Participants With Advanced Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy
|
Phase 2
|
Completed
|
NCT02283801
|
2006-11-01 |
Open-label Drug Interaction Study Between Eslicarbazepine Acetate and Lamotrigine.
|
Phase 1
|
Completed
|
NCT00402077
|
2006-11-01 |
A Study to Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese Subjects
|
Phase 2
|
Completed
|
NCT00402363
|
2006-11-01 |
Evaluation of Efficacy and Safety of Lovaza (Omega-3-Acid Ethyl Esters) in Recurrent, Symptomatic Atrial Fibrillation
|
Phase 3
|
Completed
|
NCT00423475
|
2006-10-01 |
Radiation Therapy With or Without Goserelin in Treating Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate Cancer
|
Phase 3
|
Completed
|
NCT00493064
|
2006-10-01 |
To Study the Effectiveness and Safety of Niacin and a Topical Steroid Eye Drop to Treat Retinal Vein Occlusions
|
Phase 2/Phase 3
|
Active, Not Recruiting
|
NCT00392925
|
2006-10-01 |
A Study to Evaluate the Effect on Body Weight of Leptin Administered in Conjunction With Pramlintide in Overweight and Obese Subjects
|
Phase 2
|
Completed
|
NCT00507949
|
2006-10-01 |
Study to Evaluate the Effect of Megestrol Acetate in Severe Chronic Obstructive Pulmonary Disease With Loss of Weight
|
Phase 2
|
Completed
|
NCT00398489
|
2006-10-01 |
Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery
|
Phase 2
|
Active, Not Recruiting
|
NCT00332657
|
2006-09-01 |
Anecortave Acetate Risk Reduction Trial (AART)
|
Phase 3
|
Terminated
|
NCT00373100
|
2006-09-01 |
The Efficacy of Zinc as Adjunct Therapy in the Treatment of Severe Pneumonia in Children
|
Phase 3
|
Completed
|
NCT00398528
|
2006-09-01 |
An fMRI Study of Treatment Optimization Comparing Two Disease Modifying Therapies Used to Treat Relapsing Remitting Multiple Sclerosis
|
Phase 4
|
Terminated
|
NCT01007851
|
2006-09-01 |
Single Dose Gonadotropin-releasing Hormone (GnRH) Agonist Administration in the Luteal Phase of GnRH Antagonist Stimulated ICSI-ET Cycles
|
Phase 3
|
Terminated
|
NCT00570479
|
2006-09-01 |
Prophylactic Anecortave Acetate in Patients With a Retisert Implant
|
Phase 1
|
Completed
|
NCT00337779
|
2006-08-01 |
Clinical Trial Comparing Treatment of Relapsing-Remitting Multiple Sclerosis (RR-MS) With Two Doses of Glatiramer Acetate (GA).
|
Phase 3
|
Completed
|
NCT00466076
|
2006-08-01 |
Copaxone in Age Related Macular Degeneration
|
Phase 2/Phase 3
|
Recruiting
|
NCT00370019
|
2006-08-01 |
Effects of an Estrogen Replacement Therapy Skin Patch on Ovulation in Women With Premature Ovarian Failure
|
Phase 2
|
Withdrawn
|
NCT00360490
|
2006-07-01 |
Study in Women With Idiopathic Menorrhagia to Determine the Reduction in Menstrual Blood Loss (MBL) After Treatment With the Levonorgestrel-releasing Intrauterine System (IUS)
|
Phase 3
|
Completed
|
NCT00357877
|
2006-07-01 |
Prevention of Adult Caries Study (PACS)
|
Phase 3
|
Active, Not Recruiting
|
NCT00326625
|
2006-07-01 |
Clinical Trial of Glatiramer Acetate in Amyotrophic Lateral Sclerosis (ALS)
|
Phase 2
|
Completed
|
NCT00544830
|
2006-07-01 |
Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Androgen Deprivation Therapy for Metastatic Prostate Cancer
|
Phase 2
|
Active, Not Recruiting
|
NCT00677664
|
2006-07-01 |
Effects of Copaxone in the Retinal Function in Diabetic Patients After Panphotocoagulation
|
Phase 4
|
Active, Not Recruiting
|
NCT00473746
|
2006-06-01 |
Abiraterone Acetate Dose-Escalation Study in Hormone Refractory Prostate Cancer
|
Phase 1/Phase 2
|
Completed
|
NCT00637806
|
2006-06-01 |
Treatment of Cancer-Associated Anorexia Using Megestrol Acetate Concentrated Suspension
|
Phase 3
|
Terminated
|
NCT00454571
|
2006-06-01 |
Pazopanib Hydrochloride After Leuprolide Acetate or Goserelin Acetate in Treating Patients With Relapsed Prostate Cancer
|
Phase 2
|
Active, Not Recruiting
|
NCT00637728
|
2006-06-01 |
Treatment of Cancer-Anorexia Using Megestrol Acetate Concentrated Suspension in Lung or Pancreatic Cancer Patients
|
Phase 3
|
Terminated
|
NCT00638079
|
2006-06-01 |
Evaluating the Effect of Food on Absorption of Megace ES
|
Phase 1
|
Completed
|
NCT00637403
|
2006-05-01 |
Effect of Renal Impairment on the Pharmacokinetics, and Safety of Megestrol Acetate Concentrated Suspension
|
Phase 1
|
Terminated
|
NCT00330395
|
2006-05-01 |
Open, Pharmacokinetic Study of Caspofungin in Neonates and Infants (0991-058)
|
Phase 2
|
Completed
|
NCT00313183
|
2006-04-01 |
A Study to Evaluate Symlin in Adolescent Subjects With Type 1 Diabetes Mellitus
|
Phase 2
|
Completed
|
NCT00322348
|
2006-04-01 |
Study of Zoladex Given Every 12 Weeks Versus Given Every Month in Advanced Breast Cancer (ABC) Pre-menopausal Women
|
Phase 2
|
Completed
|
NCT00348998
|
2006-04-01 |
Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer
|
Phase 2
|
Active, Not Recruiting
|
NCT00329797
|
2006-03-01 |
Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy
|
Phase 3
|
Completed
|
NCT00286481
|
2006-03-01 |
Efficacy of Lapaquistat Acetate Alone or Combined With Simvastatin in Subjects With Hypercholesterolemia
|
Phase 3
|
Completed
|
NCT00320203
|
2006-03-01 |
Anecortave Acetate in Patients With Open-angle Glaucoma
|
Phase 2
|
Completed
|
NCT00378690
|
2006-03-01 |
A Phase IIIb Study of Intermittent Versus Continuous Hormone Deprivation Treatment With ELIGARD
|
Phase 3
|
Completed
|
NCT00891293
|
2006-03-01 |
A Second Open-Label Extension of a Double-Blind, Parallel, Phase IV Study to Assess the Efficacy and Safety of Adjunctive Lovaza® (Formerly Known as Omacor®) Therapy in Hypertriglyceridemic Subjects Treated With Antara™
|
Phase 4
|
Completed
|
NCT00376064
|
2006-03-01 |
Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly
|
Phase 4
|
Completed
|
NCT00845845
|
2006-03-01 |
Fish Oil and Diet for the Treatment of Non-Alcoholic Steatohepatitis (NASH)
|
Phase 2
|
Terminated
|
NCT00306748
|
2006-03-01 |
Phase 2 Study of MD-1100 Acetate Administered for 14 Days to Patients Meeting Criteria for Chronic Constipation
|
Phase 2
|
Completed
|
NCT00548080
|
2006-03-01 |
Evaluate the Safety and Efficacy of Caspofungin Acetate as Empirical Therapy in Chinese Adults With Persistent Fever and Neutropenia (0991-055)
|
Phase 3
|
Completed
|
NCT01824602
|
2006-02-01 |
Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) in Acute Manic Episodes Associated With Bipolar I Disorder
|
Phase 2
|
Terminated
|
NCT00296153
|
2006-02-01 |
Omacor and Cardiovascular Risk Factors in HIV Patients on HAART Treatment
|
Phase 4
|
Completed
|
NCT00108732
|
2006-02-01 |
A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate Cancer
|
Phase 2
|
Active, Not Recruiting
|
NCT00275262
|
2006-02-01 |
A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function Following Bone Marrow Transplantation
|
Phase 2
|
Terminated
|
NCT01153581
|
2006-02-01 |
Sex Hormones and Orthostatic Tolerance
|
Phase 2
|
Completed
|
NCT00813527
|
2006-02-01 |
Effect of Lapaquistat Acetate Combined With Fenofibrate on Blood Cholesterol Levels
|
Phase 2
|
Completed
|
NCT00290251
|
2006-02-01 |
Treatment of Uterine Fibroids With the Selective Progesterone Receptor Modulator CDB-2914
|
Phase 2
|
Completed
|
NCT00302731
|
2006-02-01 |
Bioidentical 'Natural' Hormone Evaluation in Early Menopause
|
Phase 2
|
Completed
|
NCT00303524
|
2006-02-01 |
Comparative Study of Oestradiol Suppression: Zoladex 10.8mg/3 Month vs. 3.6mg/Month in ER +ve EBC Pre-menopausal Patients
|
Phase 2
|
Completed
|
NCT00250432
|
2006-01-01 |
A Multicenter, Randomized, Double-Blind, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of 2 Dosing Regimens of an Antifungal Drug in the Treatment of Fungal Infections in Adults (0991-801)(COMPLETED)
|
Phase 3
|
Completed
|
NCT00258193
|
2006-01-01 |
Phase 2 Study of MD-1100 Acetate on Gastrointestinal Transit in Patients With C-IBS
|
Phase 2
|
Completed
|
NCT00868127
|
2005-12-01 |
Safety of Lapaquistat Acetate in Subjects With Hypercholesterolemia
|
Phase 3
|
Completed
|
NCT00283062
|
2005-12-01 |
Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical Prostatectomy
|
Phase 3
|
Completed
|
NCT00372697
|
2005-12-01 |
Efficacy/Safety of Octreotide Acetate in Patients With Uncontrolled Acromegaly
|
Phase 3
|
Completed
|
NCT00288080
|
2005-12-01 |
Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer
|
Phase 3
|
Active, Not Recruiting
|
NCT00315640
|
2005-12-01 |
Anecortave Acetate for Treatment of Steroid Induced Intraocular Pressure (IOP) Elevation
|
Phase 2
|
Completed
|
NCT01822678
|
2005-12-01 |
Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) in Acute Manic Episodes Associated With Bipolar I Disorder
|
Phase 2
|
Completed
|
NCT00455689
|
2005-11-01 |
Understanding Experimentally Induced Hot Flushes
|
Phase 2/Phase 3
|
Active, Not Recruiting
|
NCT00473512
|
2005-11-01 |
A Safety and Efficacy Study of Abiraterone Acetate in Participants With Prostate Cancer Who Have Failed Hormone Therapy
|
Phase 1/Phase 2
|
Completed
|
NCT00249899
|
2005-11-01 |
Efficacy of Lapaquistat Acetate Alone or Combined With High-Dose Statin Therapy in Subjects With Hypercholesterolemia
|
Phase 3
|
Terminated
|
NCT00903409
|
2005-11-01 |
Open-Label Extension of a Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Lovaza® and Simvastatin Therapy in Hypertriglyceridemic Subjects
|
Phase 3
|
Completed
|
NCT00248131
|
2005-11-01 |
Extension Study of Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy
|
Phase 3
|
Terminated
|
NCT00248157
|
2005-11-01 |
Extension Study of the Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy
|
Phase 3
|
Terminated
|
NCT00263081
|
2005-11-01 |
Efficacy of Lapaquistat Acetate Co-Administered With Current Lipid-Lowering Treatment on Blood Cholesterol Levels in Subjects With Homozygous Familial Hypercholesterolemia
|
Phase 3
|
Terminated
|
NCT00240253
|
2005-10-01 |
A Study Evaluating the Efficacy and Safety of Adding Symlin® to Lantus® (Insulin Glargine) in Subjects With Type 2 Diabetes
|
Phase 4
|
Completed
|
NCT00249912
|
2005-10-01 |
Efficacy of Lapaquistat Acetate Alone or Combined With Rosuvastatin in Subjects With Hypercholesterolemia
|
Phase 3
|
Completed
|
NCT00268697
|
2005-10-01 |
Efficacy of Lapaquistat Acetate Alone and With Ezetimibe in Subjects With Primary Dyslipidemia.
|
Phase 3
|
Completed
|
NCT00256178
|
2005-10-01 |
Efficacy of Lapaquistat Acetate and Simvastatin in Subjects With Primary Dyslipidemia.
|
Phase 3
|
Completed
|
NCT00251680
|
2005-10-01 |
Efficacy of Lapaquistat Acetate in Subjects Currently Treated With Lipid-Lowering Therapy.
|
Phase 3
|
Completed
|
NCT00182754
|
2005-10-01 |
Octreotide in Treating Patients With Cancer-Related Malignant Ascites
|
Phase 3
|
Active, Not Recruiting
|
NCT00189514
|
2005-09-01 |
A Study to Examine the Long Term Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects
|
Phase 2
|
Completed
|
NCT00225433
|
2005-09-01 |
Luteal Phase FSH in the IVF Poor Responder
|
Phase 4
|
Completed
|
NCT00211458
|
2005-09-01 |
Treatment of Age-Related Macular Degeneration With Anecortave Acetate
|
Phase 2
|
Completed
|
NCT00128531
|
2005-09-01 |
Leuprolide Acetate 3.75 mg Depot to Treat Prostate Cancer
|
Phase 3
|
Completed
|
NCT00217659
|
2005-09-01 |
S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer
|
Phase 2
|
Withdrawn
|
NCT00143663
|
2005-09-01 |
Effect of Lapaquistat Acetate on Blood Cholesterol Levels in Subjects With Elevated Cholesterol
|
Phase 3
|
Completed
|
NCT00146211
|
2005-09-01 |
TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease
|
Phase 3
|
Completed
|
NCT00143676
|
2005-08-01 |
Efficacy of Lapaquistat Acetate and Atorvastatin on Blood Cholesterol Levels in Subjects With Primary Hypercholesterolemia
|
Phase 3
|
Completed
|
NCT00239993
|
2005-08-01 |
A Study to Evaluate the Impact of Using Warm Compress Prior to Daily Injections of Copaxone®
|
Phase 4
|
Completed
|
NCT00225420
|
2005-08-01 |
Docetaxel, Androgen Ablation Therapy, and External-Beam Radiation Therapy in Treating Patients With High-Risk Localized Prostate Cancer
|
Phase 1/Phase 2
|
Completed
|
NCT00257426
|
2005-07-01 |
Octreotide in Treating Patients With Locally Advanced or Metastatic Liver Cancer
|
Phase 2
|
Completed
|
NCT00707421
|
2005-07-01 |
Usefulness of Topical Non-Steroidal Anti-Inflammatory Drugs or Steroids Before Trabeculectomy and Clinical Outcomes
|
Phase 3
|
Completed
|
NCT00123110
|
2005-07-01 |
Insulin Resistance and Testosterone in Women
|
Phase 2
|
Completed
|
NCT00226655
|
2005-07-01 |
An Open-Labeled, Extended-Use of XERECEPT (hCRF) for Patients in Studies NTI 0302, 0303, or Other Designated Studies
|
Phase 3
|
Completed
|
NCT02170064
|
2005-06-01 |
Pharmacokinetics, Efficacy and Tolerability of BIA 2-093
|
Phase 2
|
Completed
|
NCT00379964
|
2005-06-01 |
A 28 - 90 Days Study to Evaluate the Safety, Tolerability, and Efficacy of Caspofungin Injection as Empirical Therapy in Indian Adults With Persistent Fever and Neutropenia (0991-053)(COMPLETED)
|
Phase 3
|
Completed
|
NCT00127075
|
2005-06-01 |
POPART'MUS: Prevention of Post Partum Relapses With Progestin and Estradiol in Multiple Sclerosis
|
Phase 3
|
Active, Not Recruiting
|
NCT00211978
|
2005-05-01 |
EPIC(Effect of PhosLo on Phosphorus Levels in Chronic Kidney Disease)
|
Phase 3
|
Completed
|
NCT00112281
|
2005-05-01 |
A Study of the Safety and Efficacy of Nitric Oxide Reduction in Patients With Cardiogenic Shock After a Heart Attack
|
Phase 3
|
Terminated
|
NCT00148330
|
2005-05-01 |
Open Label Extension of a Clinical Trial of Intravitreal Triamcinolone for Diabetic Macular Oedema-TDMX Study
|
Phase 2/Phase 3
|
Completed
|
NCT00273728
|
2005-05-01 |
BaSES Trial: Basel Starch Evaluation in Sepsis
|
Phase 4
|
Completed
|
NCT00333216
|
2005-05-01 |
Anecortave Acetate Risk-Reduction Trial (AART)
|
Phase 3
|
Terminated
|
NCT00118482
|
2005-05-01 |
Clinical Trial for the Prevention of Vasovagal Syncope
|
Phase 4
|
Completed
|
NCT00112021
|
2005-05-01 |
A Study to Examine the Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects
|
Phase 2
|
Completed
|
NCT00107666
|
2005-04-01 |
CTI-01 (Ethyl Pyruvate) Safety and Complication Prevention in Cardiac Surgery Patients on Cardiopulmonary Bypass (CPB)
|
Phase 2
|
Terminated
|
NCT00148265
|
2005-04-01 |
A Multicentre Randomised Clinical Trial of Laser Treatment Plus Intravitreal Triamcinolone for Diabetic Macular Oedema
|
Phase 2/Phase 3
|
Completed
|
NCT00299507
|
2005-03-01 |
Anecortave Acetate in Patients With Exudative Age-related Macular Degeneration (AMD)
|
Phase 3
|
Completed
|
NCT01477632
|
2005-03-01 |
Bioavailability of Three Oral Formulations for Hormone Replacement Therapy in Postmenopausal Women
|
Phase 1
|
Completed
|
NCT00135226
|
2005-03-01 |
ASCEND: A Study of Cardiovascular Events iN Diabetes
|
Phase 4
|
Active, Not Recruiting
|
NCT00110045
|
2005-02-01 |
Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant
|
Phase 2
|
Completed
|
NCT00211939
|
2005-01-01 |
CARE-2 (Calcium Acetate [PhosLo®]/Sevelamer[Renagel®] Evaluation Study 2) for Heart Calcification in Dialysis Patients
|
Phase 4
|
Completed
|
NCT00211887
|
2005-01-01 |
Combination Therapy in Patients With Relapsing-Remitting Multiple Sclerosis (MS)CombiRx
|
Phase 3
|
Completed
|
NCT00203047
|
2005-01-01 |
Assessment Study of Steroid Effect in Relapsing Multiple Sclerosis Subjects Treated With Glatiramer Acetate
|
Phase 4
|
Terminated
|
NCT00196755
|
2004-12-01 |
Study of Safety and Efficacy of Renagel® Compared With Calcium Acetate in Patients With Peritoneal Dialysis
|
Phase 3
|
Completed
|
NCT00637572
|
2004-12-01 |
Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-Related Weight Loss
|
Phase 2
|
Completed
|
NCT00203099
|
2004-12-01 |
Safety and Efficacy Study of Copaxone Administered in Combination With N-Acetylcysteine
|
Phase 2
|
Completed
|
NCT00957372
|
2004-12-01 |
Efficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial Epilepsy
|
Phase 3
|
Completed
|
NCT00839449
|
2004-12-01 |
Eicosapentaenoic Acid Cerebral Vasospasm Therapy Study
|
Phase 4
|
Completed
|
NCT00487994
|
2004-11-01 |
Safety and Efficacy of Lapaquistat Acetate Taken Alone and With Atorvastatin in Subjects With Primary Dyslipidemia
|
Phase 3
|
Completed
|
NCT00240032
|
2004-10-01 |
A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Taking an Antihistamine (Zyrtec®) or Placebo Prior to Daily Injections of Copaxone®.
|
Phase 4
|
Completed
|
NCT00103376
|
2004-10-01 |
Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer
|
Phase 2
|
Completed
|
NCT00104715
|
2004-10-01 |
Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancer
|
Phase 3
|
Active, Not Recruiting
|
NCT00193856
|
2004-10-01 |
RADAR Trial - Randomised Androgen Deprivation and Radiotherapy
|
Phase 3
|
Active, Not Recruiting
|
NCT00212368
|
2004-10-01 |
Efficacy and Safety Study of Zinc Acetate to Treat Wilson's Disease in Japan.
|
Phase 3
|
Completed
|
NCT00752635
|
2004-09-01 |
Comparison of Efficacy and Safety of Norgestimate-ethinyl Estradiol and Cyproterone Acetate-ethinyl Estradiol in the Treatment of Acne Vulgaris
|
Phase 4
|
Completed
|
NCT00864643
|
2004-09-01 |
Efficacy and Safety of Lapaquistat Acetate Coadministered With Atorvastatin in Subjects With Hypercholesterolemia
|
Phase 2
|
Completed
|
NCT00170729
|
2004-08-01 |
A Study to Compare Ocular Safety and Tolerability of Eye Drops Containing Prednisolone Acetate in Patients With Intraocular Inflammation After Cataract Surgery
|
Phase 4
|
Completed
|
NCT00427245
|
2004-08-01 |
Goserelin in Preventing Early Menopause in Premenopausal Women Undergoing Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer
|
Phase 3
|
Completed
|
NCT00349258
|
2004-08-01 |
The Use of GnRH Agonist Trigger in the Prevention of OHSS
|
Phase 4
|
Completed
|
NCT00134992
|
2004-08-01 |
A Study to Compare Ocular Safety and Tolerability of Prednisolone Acetate 0.5% Eye Drops Versus Vehicle in Healthy Volunteers
|
Phase 4
|
Completed
|
NCT00444561
|
2004-08-01 |
An Exploratory Study to Evaluate Various Pharmacodynamic Effects of Subcutaneously Infused or Injected Pramlintide in Obese Subjects
|
Phase 2
|
Completed
|
NCT00458458
|
2004-08-01 |
Treatment of Endometriosis With Norethindrone Acetate ( NA) VS. Gonadotropin- Releasing Hormone (GnRH) Agonist (Lupron Depot 11.25 mg)
|
Phase 3
|
Active, Not Recruiting
|
NCT00099086
|
2004-07-01 |
Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer
|
Phase 1
|
Active, Not Recruiting
|
NCT00202995
|
2004-07-01 |
Randomized Study Designed to Look at Disease Progression Using 2 Currently FDA Approved Drugs for the Treatment of RRMS
|
Phase 4
|
Terminated
|
NCT00957047
|
2004-07-01 |
Efficacy and Safety Study of BIA 2-093 in Combination With Other Anti-Epileptic Drugs to Treat Partial Epilepsy
|
Phase 3
|
Completed
|
NCT00957684
|
2004-07-01 |
Efficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial Seizures
|
Phase 3
|
Completed
|
NCT00081159
|
2004-07-01 |
Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases
|
Phase 2
|
Completed
|
NCT00584857
|
2004-07-01 |
A Phase II Study of Therapy With Paclitaxel, Carboplatin and Megesterol Acetate for the Management of Uterine Cancer
|
Phase 2
|
Completed
|
NCT00203112
|
2004-06-01 |
Safety and Efficacy Study of Copaxone Administered in Combination With Minocycline
|
Phase 2
|
Completed
|
NCT00184795
|
2004-05-01 |
Bleed Free Treatment of Menopausal Symptoms With New Ultra Low Dose Hormonal Combinations
|
Phase 3
|
Completed
|
NCT00292071
|
2004-05-01 |
Open, Pharmacokinetic Study of Caspofungin Acetate in Immunocompromised Young Children With Febrile Neutropenia (0991-042)
|
Phase 2
|
Completed
|
NCT00211367
|
2004-04-01 |
Treatment of Radiation Retinopathy With Open-Label Anecortave Acetate Sterile Suspension (15 mg)
|
Phase 2
|
Terminated
|
NCT00082537
|
2004-04-01 |
MK0991 Versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients (0991-044)
|
Phase 2
|
Completed
|
NCT00082524
|
2004-04-01 |
Documented Candida or Aspergillus Infections in Pediatric Patients (0991-043)
|
Phase 2
|
Completed
|
NCT01011751
|
2004-04-01 |
Treatment of Hot Flushes Caused by Leuprorelin 11.25 mg in Prostate Adenocarcinoma
|
Phase 3
|
Completed
|
NCT00428311
|
2004-04-01 |
Effects of Metformin vs Oral Contraceptives on CV Risk Markers in PCOS
|
Phase 4
|
Completed
|
NCT00307398
|
2004-03-01 |
Anecortave Acetate Risk-Reduction Trial (AART)
|
Phase 3
|
Terminated
|
NCT00075192
|
2004-03-01 |
CP-675,206 With Neoadjuvant Hormone Therapy in Patients With High Risk Prostate Cancer
|
Phase 1/Phase 2
|
Completed
|
NCT00078338
|
2004-03-01 |
Rebif® Versus Copaxone® in the Treatment of Relapsing Remitting Multiple Sclerosis
|
Phase 4
|
Completed
|
NCT00083824
|
2004-03-01 |
Estrogen, HDL, and Coronary Heart Disease in Women
|
Phase 2/Phase 3
|
Completed
|
NCT00070148
|
2004-03-01 |
Oxandrolone Compared With Megestrol in Preventing Weight Loss in Patients Receiving Chemotherapy for Cancer
|
Phase 3
|
Completed
|
NCT00932321
|
2004-01-01 |
Study of Safety and Efficacy of an Oral Contraceptive
|
Phase 3
|
Completed
|
NCT00666224
|
2004-01-01 |
Evaluate Early Glatiramer Acetate Treatment in Delaying Conversion to Clinically Definite Multiple Sclerosis of Subjects Presenting With Clinically Isolated Syndrome
|
Phase 3
|
Completed
|
NCT00076440
|
2003-12-01 |
Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study
|
Phase 2
|
Completed
|
NCT00076531
|
2003-12-01 |
Clinical Trial for Prostate Cancer
|
Phase 3
|
Completed
|
NCT00075868
|
2003-12-01 |
Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer
|
Phase 3
|
Completed
|
NCT00466856
|
2003-12-01 |
Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors
|
Phase 2
|
Terminated
|
NCT00767286
|
2003-11-01 |
Goserelin, Flutamine, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer
|
Phase 3
|
Completed
|
NCT00987376
|
2003-11-01 |
Novel PET/CT Agents and MRS/MRI in Prostate CA and High Risk Prostate Cancer: An Inter-SPORE Collaboration
|
Phase 1
|
Completed
|
NCT00068601
|
2003-10-01 |
S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
|
Phase 3
|
Active, Not Recruiting
|
NCT00238355
|
2003-08-01 |
Voriconazole and Caspofungin Acetate in Treating Invasive Fungal Infections in Patients With Weakened Immune Systems
|
Phase 2
|
Terminated
|
NCT00294216
|
2003-08-01 |
Omacor and Placebo in Carotid Plaque Stability
|
Phase 3
|
Completed
|
NCT00202982
|
2003-08-01 |
A Study to Test the Effectiveness and Safety of a New Higher 40mg Dose of Copaxone® Compared to Copaxone® 20mg, the Currently Approved Dose
|
Phase 2
|
Completed
|
NCT00835211
|
2003-07-01 |
Desmopressin Acetate 0.2 mg Tablets, Fasting
|
Phase 1
|
Completed
|
NCT00290589
|
2003-06-01 |
A Trial of Corticosteroids for Low Back Pain
|
Phase 3
|
Completed
|
NCT00500110
|
2003-06-01 |
Hormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate Cancer
|
Phase 2
|
Completed
|
NCT00203073
|
2003-06-01 |
A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone for Multiple Sclerosis.
|
Phase 2
|
Completed
|
NCT00065728
|
2003-06-01 |
Open-Label Posterior Juxtascleral Injections of Anecortave Acetate 15mg Dose for Long Term Use in Patients With AMD
|
Phase 3
|
Terminated
|
NCT00267319
|
2003-06-01 |
FOCUS Fatigue Outcome in Copaxone USers
|
Phase 4
|
Completed
|
NCT00066248
|
2003-06-01 |
Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment
|
Phase 2
|
Completed
|
NCT00067015
|
2003-05-01 |
Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer
|
Phase 3
|
Completed
|
NCT00211484
|
2003-05-01 |
Treatment of Conditions With Open Label-Anecortave Acetate Sterile Suspension ( 15mg.) Where Lesions do Not Meet Acceptable Criteria for Standard Care.
|
Phase 2
|
Completed
|
NCT00220194
|
2003-04-01 |
A Six-Month, Open-Label, Crossover Study Of the Maintenance Of Serum Testosterone And PSA Suppression After Switching Between Lupron 22.5 Mg And Eligard 22.5 Mg Or Zoladex 10.8 Mg And Eligard 22.5 Mg In Patients With Advanced Prostate Cancer
|
Phase 4
|
Completed
|
NCT00108004
|
2003-04-01 |
Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus
|
Phase 3
|
Completed
|
NCT00621179
|
2003-03-01 |
Endometrial Markers and Response of Endometriosis Patients to Prolonged GnRH Agonist Prior to IVF
|
Phase 4
|
Completed
|
NCT00328614
|
2003-03-01 |
Samarium-153 With Neoadjuvant Hormonal and Radiation Therapy for Locally Advanced Prostate Cancer
|
Phase 1
|
Completed
|
NCT00063310
|
2003-03-01 |
ALADDIN Study: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation
|
Phase 2
|
Completed
|
NCT00058994
|
2003-03-01 |
An Evaluation of Safety and Efficacy of Anecortave Acetate Versus Placebo in Patients With Subfoveal CNV Due to Exudative AMD
|
Phase 3
|
Completed
|
NCT00242541
|
2003-03-01 |
Study Assessing the Efficacy and Safety of Octreotide Acetate in Patients With Acromegaly, With Micro or Macroadenomas
|
Phase 4
|
Terminated
|
NCT00801957
|
2003-03-01 |
Equivalence of the Response to Vaccination of Tacrolimus Ointment to a Steroid Ointment Regimen in Children With Atopic Dermatitis
|
Phase 2
|
Completed
|
NCT00294463
|
2003-02-01 |
Effects of Tibolone Treatment on the Endometrium
|
Phase 4
|
Completed
|
NCT01070979
|
2003-02-01 |
Hormone Replacement Therapy for Use in Postmenopausal Women for Relief of Hot Flushes and Urogenital Symptoms.
|
Phase 3
|
Completed
|
NCT00076869
|
2003-01-01 |
MK0991 in Combination With Standard Antifungal Agent(s) for the Treatment of Salvage Invasive Aspergillosis (0991-037)
|
Phase 2
|
Completed
|
NCT00363285
|
2003-01-01 |
Cyproterone Acetate in Treating Patients With Newly Diagnosed Stage III or Stage IV Prostate Cancer
|
Phase 3
|
Recruiting
|
NCT00635154
|
2002-12-01 |
Anakinra With or Without Dexamethasone in Treating Patients With Smoldering or Indolent Multiple Myeloma
|
Phase 2
|
Completed
|
NCT00001079
|
2002-12-01 |
A Study of Megestrol Acetate Alone or in Combination With Testosterone Enanthate Drug in the Treatment of HIV-Associated Weight Loss
|
Phase 2
|
Completed
|
NCT00257283
|
2002-11-01 |
Omacor in Prevention of Cardiovascular Events in Patients Undergoing Chronic Hemodialysis
|
Phase 4
|
Completed
|
NCT00429494
|
2002-11-01 |
GnRH Analogue for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients
|
Phase 2
|
Completed
|
NCT00055731
|
2002-11-01 |
Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse
|
Phase 3
|
Active, Not Recruiting
|
NCT00053911
|
2002-11-01 |
Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast Cancer
|
Phase 3
|
Terminated
|
NCT00107107
|
2002-11-01 |
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
|
Phase 3
|
Completed
|
NCT01878578
|
2002-11-01 |
The Effect of BIA 2-093 on the Steady-state Pharmacokinetic Profile of Phenytoin in Patients
|
Phase 1
|
Terminated
|
NCT00392535
|
2002-10-01 |
Intensity-Modulated Radiation Therapy in Treating Patients With Localized Prostate Cancer
|
Phase 3
|
Recruiting
|
NCT00345046
|
2002-09-01 |
A Comparison of Three Different Formulations of Prednisolone Acetate 1%
|
Phase 4
|
Completed
|
NCT00044707
|
2002-08-01 |
Evaluation of an Orally Administered Medication When Taken in Conjunction With Pramlintide
|
Phase 2
|
Completed
|
NCT01160315
|
2002-07-01 |
Efficiency of Gonadotropin-releasing Hormone (GnRH) Agonist in Preventing Chemotherapy Induced Ovarian Failure
|
Phase 2/Phase 3
|
Active, Not Recruiting
|
NCT00042601
|
2002-07-01 |
Evaluation of the Effect of Pramlintide on Satiety and Food Intake
|
Phase 2
|
Completed
|
NCT00042471
|
2002-06-01 |
Evaluation of the Bioavailability of Pramlintide
|
Phase 2
|
Completed
|
NCT00041483
|
2002-06-01 |
Phase 3 Study to Evaluate Anecortave Acetate vs. Visudyne for the Treatment of the Wet Form of AMD
|
Phase 3
|
Completed
|
NCT00041275
|
2002-05-01 |
Megestrol in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
|
Phase 3
|
Completed
|
NCT00033605
|
2002-04-01 |
Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis
|
Phase 3
|
Completed
|
NCT00830414
|
2002-04-01 |
Medroxyprogesterone Acetate Injection 150 mg/1 mL in Postmenopausal Women
|
Phase 1
|
Completed
|
NCT00042458
|
2002-04-01 |
Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose Control
|
Phase 3
|
Completed
|
NCT00167518
|
2002-03-01 |
Intravitreal Triamcinolone for Clinically Significant Diabetic Macular Oedema That Persists After Laser Treatment (TDMO)
|
Phase 2/Phase 3
|
Completed
|
NCT00653757
|
2002-03-01 |
Intensity-Modulated Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Prostate Cancer
|
Phase 1/Phase 2
|
Completed
|
NCT00211471
|
2002-03-01 |
Treatment of Rubeosis Iridis With Open-Label Anecortave Acetate Sterile Suspension ( 15 mg.).
|
Phase 2
|
Terminated
|
NCT00211354
|
2002-03-01 |
Treatment of Retinal Vein Occlusion (RVO) With Open-Label Anecortave Acetate (15mg.)
|
Phase 2
|
Withdrawn
|
NCT00211328
|
2002-03-01 |
Treatment of Idiopathic Perifoveal Telangiectasia (IPT) With Open-Label Anecortave Acetate (15mg.).
|
Phase 2
|
Completed
|
NCT00211315
|
2002-03-01 |
Treatment of Congenital Telangiectasia (Coat's Disease) With Open-label Anecortave Acetate (15mg.)
|
Phase 2
|
Completed
|
NCT00332553
|
2002-02-01 |
Study of Hot Flashes and Night Sweats in Postmenopausal Women Receiving Combination Raloxifene and Oral Estrogen
|
Phase 2
|
Completed
|
NCT00032006
|
2002-02-01 |
Hormone Therapy Followed By Internal Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer
|
Phase 2
|
Completed
|
NCT00244920
|
2002-01-01 |
Hormone Therapy With or Without Squalamine Lactate in Treating Patients Who Are Undergoing a Radical Prostatectomy for Locally Advanced Prostate Cancer
|
Phase 2
|
Withdrawn
|
NCT00205777
|
2001-12-01 |
Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women
|
Phase 3
|
Completed
|
NCT01237327
|
2001-11-01 |
Multicenter Follow Up Study Of Subjects Who Participated In An Original Protocol Of Exemestane Vs. Megestrol Acetate In Postmenopausal Women With Metastatic Breast Cancer
|
Phase 3
|
Completed
|
NCT00026377
|
2001-11-01 |
SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
|
Phase 1
|
Completed
|
NCT00283803
|
2001-10-01 |
To Lengthen the Duration of the Off-Treatment of Intermittent Androgen Suppression
|
Phase 2
|
Active, Not Recruiting
|
NCT00220350
|
2001-10-01 |
Lupron Sex Offender Therapy
|
Phase 2/Phase 3
|
Active, Not Recruiting
|
NCT00096798
|
2001-09-01 |
Ethyl Eicosapentanoic Acid (Ethyl-EPA) for Treating Major Depression
|
Phase 3
|
Completed
|
NCT00634361
|
2001-09-01 |
Ethyl-EPA Treatment of Prodromal Patients
|
Phase 2/Phase 3
|
Completed
|
NCT00419146
|
2001-09-01 |
Treatment of Schizophrenia With an Omega-3 Fatty Acid (EPA) and Antioxidants
|
Phase 2/Phase 3
|
Completed
|
NCT00047099
|
2001-08-01 |
Combination Chemotherapy in Treating Women With Breast Cancer
|
Phase 3
|
Completed
|
NCT01705249
|
2001-08-01 |
Bleeding Profile With Continuous Hormone Replacement Therapy of Activelle® in Postmenopausal Women
|
Phase 4
|
Completed
|
NCT00481169
|
2001-07-01 |
Study Evaluating TSE-424/Placebo/Raloxifene in Preventing Osteoporosis in Postmenopausal Women
|
Phase 3
|
Completed
|
NCT00169299
|
2001-06-01 |
Herbal Alternatives for Menopause Symptoms (HALT Study)
|
Phase 4
|
Active, Not Recruiting
|
NCT00632983
|
2001-06-01 |
Active Surveillance, Radical Prostatectomy, or Radiation Therapy in Treating Patients With Localized Prostate Cancer
|
Phase 3
|
Active, Not Recruiting
|
NCT00016341
|
2001-05-01 |
Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer
|
Phase 3
|
Terminated
|
NCT00021450
|
2001-04-01 |
Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer
|
Phase 3
|
Active, Not Recruiting
|
NCT00014586
|
2001-01-01 |
Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate Cancer
|
Phase 3
|
Terminated
|
NCT00006799
|
2000-10-01 |
Megestrol to Limit Weight Loss and Improve Quality of Life in Treating Patients With Head and Neck Cancer
|
Phase 3
|
Completed
|
NCT00031785
|
2000-09-01 |
Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung Cancer
|
Phase 3
|
Completed
|
NCT00012090
|
2000-09-01 |
Bicalutamide and Goserelin in Treating Patients With Cancer of the Ovary, Fallopian Tube, or Peritoneum
|
Phase 2
|
Completed
|
NCT00008359
|
2000-08-01 |
Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment
|
Phase 3
|
Completed
|
NCT00010010
|
2000-06-01 |
Exemestane Plus Goserelin in Treating Premenopausal Women With Metastatic Breast Cancer
|
Phase 2
|
Completed
|
NCT00346866
|
2000-05-01 |
Anecortave Acetate Versus Placebo in AMD Patients Following PDT
|
Phase 2
|
Completed
|
NCT00684905
|
2000-04-01 |
Leuprolide, Bicalutamide, and Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer After External-Beam Radiation Therapy
|
Phase 2
|
Completed
|
NCT01697384
|
2000-04-01 |
Study to Evaluate Efficacy and Safety of Histrelin Subdermal Implant in Men With Advanced Prostate Cancer
|
Phase 3
|
Completed
|
NCT00031707
|
2000-03-01 |
Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Cancer-Related Weight Loss and Lack of Appetite
|
Phase 3
|
Completed
|
NCT00004635
|
2000-02-01 |
Thalidomide for the Treatment of Hormone-Dependent Prostate Cancer
|
Phase 3
|
Completed
|
NCT00130845
|
2000-02-01 |
Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy
|
Phase 3
|
Completed
|
NCT01472315
|
2000-01-01 |
Postmenopausal Women,Treatment of Sleep Apnea and Co-morbidities
|
Phase 2/Phase 3
|
Completed
|
NCT00004912
|
2000-01-01 |
Megestrol and Exercise in Treating Patients With Cancer-Related Weight Loss
|
Phase 2
|
Completed
|
NCT00006269
|
1999-12-01 |
Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon Cancer
|
Phase 3
|
Terminated
|
NCT00291369
|
1999-12-01 |
Cytokines in Patients With Metastatic Renal Cell Carcinoma of Intermediate Prognosis
|
Phase 3
|
Completed
|
NCT00005623
|
1999-12-01 |
Cyproterone Acetate in Treating Hot Flashes Following Surgical or Chemical Castration for Prostate Cancer
|
Phase 3
|
Completed
|
NCT00131144
|
1999-11-01 |
Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy
|
Phase 3
|
Completed
|
NCT00004895
|
1999-10-01 |
Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery
|
Phase 2
|
Completed
|
NCT00001146
|
1999-10-01 |
Omega-3 Fatty Acids in the Treatment of Bipolar Disorder: A Double-Blind, Placebo-Controlled Trial
|
Phase 2
|
Completed
|
NCT00003645
|
1999-06-01 |
Hormone Therapy in Treating Patients Who Have Stage I or Stage II Prostate Cancer
|
Phase 3
|
Active, Not Recruiting
|
NCT00003915
|
1999-05-01 |
Chemotherapy and Hormone Therapy in Treating Patients With Prostate Cancer
|
Phase 2
|
Active, Not Recruiting
|
NCT00346957
|
1999-04-01 |
A Phase II Study of Anecortave Acetate for the Treatment of Exudative Age-Related Macular Degeneration
|
Phase 2
|
Completed
|
NCT00321126
|
1999-01-01 |
Zinc Supplementation in Shigella Patients
|
Phase 3
|
Completed
|
NCT00003653
|
1999-01-01 |
Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer
|
Phase 3
|
Completed
|
NCT00004058
|
1998-12-01 |
12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder
|
Phase 1
|
Terminated
|
NCT00003283
|
1998-07-01 |
Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma
|
Phase 2
|
Completed
|
NCT00003394
|
1998-04-01 |
Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer
|
Phase 1/Phase 2
|
Completed
|
NCT00005975
|
1998-04-01 |
S9626: Megestrol in Treating Hot Flashes Following Treatment for Breast Cancer
|
Phase 3
|
Completed
|
NCT00002779
|
1998-02-01 |
Fludarabine Plus Octreotide in Treating Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma
|
Phase 2
|
Active, Not Recruiting
|
NCT00002996
|
1998-02-01 |
Flecainide in Treating Patients With Chronic Neuropathic Pain
|
Phase 2
|
Completed
|
NCT00091728
|
1997-09-01 |
Hormonal Contraception and Risk of Chlamydia and Gonorrhea
|
Phase 4
|
Terminated
|
NCT00003771
|
1997-09-01 |
Hormone Replacement Therapy and the Risk of Breast Cancer Recurrence in Women With Previous Early Stage Breast Cancer
|
Phase 3
|
Completed
|
NCT00002889
|
1997-05-01 |
Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer
|
Phase 2
|
Completed
|
NCT00003124
|
1997-05-01 |
Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer
|
Phase 2
|
Completed
|
NCT00223665
|
1997-01-01 |
Intermittent Hormone Therapy in Men With Localized Prostate Cancer After Radiation Therapy or Radical Prostatectomy
|
Phase 2
|
Recruiting
|
NCT00003057
|
1996-11-01 |
Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer
|
Phase 3
|
Completed
|
NCT00231738
|
1996-11-01 |
Protective Effect of EPA on Cardiovascular Events
|
Phase 4
|
Completed
|
NCT00002881
|
1996-10-01 |
Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer
|
Phase 3
|
Completed
|
NCT00002864
|
1996-08-01 |
Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer
|
Phase 3
|
Completed
|
NCT00008073
|
1996-01-01 |
Octreotide and Doxorubicin in Treating Patients With Advanced Cancer
|
Phase 1
|
Completed
|
NCT00002651
|
1995-05-01 |
Hormone Therapy in Treating Men With Stage IV Prostate Cancer
|
Phase 3
|
Recruiting
|
NCT00769548
|
1995-04-01 |
Radiation Therapy and Hormone Therapy in Treating Patients With Prostate Cancer
|
Phase 3
|
Active, Not Recruiting
|
NCT00002633
|
1995-03-01 |
Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer
|
Phase 3
|
Completed
|
NCT00002597
|
1994-10-01 |
Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer
|
Phase 3
|
Completed
|
NCT00203021
|
1994-07-01 |
Copaxone® Study to Follow Patients From the First Original Study for Safety and Effectiveness.
|
Phase 4
|
Active, Not Recruiting
|
NCT00002680
|
1994-02-01 |
Sequential High-Dose Chemotherapy and Stem Cell Transplantation in Treating Patients With Chemotherapy-Sensitive Metastatic Breast Cancer
|
Phase 2
|
Completed
|
NCT00004338
|
1993-10-01 |
Study of Zinc for Wilson Disease
|
Phase 4
|
Completed
|
NCT00002582
|
1993-06-01 |
Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer
|
Phase 3
|
Completed
|
NCT00002580
|
1993-06-01 |
Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer
|
Phase 3
|
Completed
|
NCT00660010
|
1991-01-01 |
Study of Lupron Depot In The Treatment of Central Precocious Puberty
|
Phase 3
|
Completed
|
NCT00004311
|
1989-07-01 |
Phase II Study of the Effect of Leuprolide Acetate and Spironolactone on Insulin Resistance in Hyperandrogenic Women With Polycystic Ovarian Disease or Hyperandrogenism Insulin Resistance Acanthosis Nigricans Syndrome
|
Phase 2
|
Completed
|
NCT00191113
|
1989-02-01 |
Somatropin Treatment to Final Height in Turner Syndrome
|
Phase 3
|
Completed
|
NCT00002465
|
1987-12-01 |
High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma
|
Phase 1/Phase 2
|
Active, Not Recruiting
|
NCT00002460
|
1987-09-01 |
Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer
|
Phase 3
|
Active, Not Recruiting
|
NCT00849082
|
1987-05-01 |
Radiation Therapy With or Without Goserelin and Cyproterone in Treating Patients With Prostate Cancer
|
Phase 3
|
Completed
|